: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

Vaccines

Free Subscription

Articles published in Clin Infect Dis
Retrieve available abstracts of 398 articles:
HTML format

Single Articles

July 2024

EDOSA M, Jeon Y, Gedefaw A, Hailu D, et al
Comprehensive Review on the Use of Oral Cholera Vaccine (OCV) in Ethiopia: 2019 to 2023.
Clin Infect Dis. 2024;79.
PubMed Abstract available

HUSSEN M, Worku Demlie Y, Edosa M, Kebede M, et al
Ethiopia National Cholera Elimination Plan 2022-2028: Experiences, Challenges, and the Way Forward.
Clin Infect Dis. 2024;79.
PubMed Abstract available

PARK SE, Gedefaw A, Hailu D, Jeon Y, et al
Coverage of Two-Dose Preemptive Cholera Mass Vaccination Campaign in High-Priority Hotspots in Shashemene, Oromia Region, Ethiopia.
Clin Infect Dis. 2024;79.
PubMed Abstract available

BORJA-TABORA C, Fernando L, Lopez Medina E, Reynales H, et al
Immunogenicity, safety, and efficacy of a tetravalent dengue vaccine in children and adolescents: an analysis by age group.
Clin Infect Dis. 2024 Jul 12:ciae369. doi: 10.1093.
PubMed Abstract available

JOHNSTON TS, Hage C, Abedon AT, Panda S, et al
Rapid Wane and Recovery of XBB Sublineage Neutralization After Sequential Omicron-based Vaccination in Solid Organ Transplant Recipients.
Clin Infect Dis. 2024 Jul 2:ciae279. doi: 10.1093.
PubMed Abstract available

June 2024

RUSS RK, Vandehei HM, Golovkina MI, Mogallapalli H, et al
Hepatitis B-CpG vaccine series for healthcare workers who are hepatitis B vaccine nonresponders.
Clin Infect Dis. 2024 Jun 17:ciae320. doi: 10.1093.
PubMed Abstract available

May 2024

WOLFE DN, Arangies E, David GL, Armstrong B, et al
Development of Next-Generation COVID-19 Vaccines: BARDA Supported Phase 2b Study Designs.
Clin Infect Dis. 2024 May 28:ciae286. doi: 10.1093.
PubMed Abstract available

HILL JA, Martens MJ, Young JH, Bhavsar K, et al
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study.
Clin Infect Dis. 2024 May 27:ciae291. doi: 10.1093.
PubMed Abstract available

JORGENSEN SCJ, Brown K, Clarke AE, Schwartz KL, et al
The Effect of COVID-19 Vaccination on Outpatient Antibiotic Prescribing in Older Adults: A Self-Controlled Risk-Interval Study.
Clin Infect Dis. 2024 May 3:ciae182. doi: 10.1093.
PubMed Abstract available

April 2024

Correction to: Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant Recipients.
Clin Infect Dis. 2024 Apr 30:ciae164. doi: 10.1093.
PubMed

MWESIGWA B, Sawe F, Oyieko J, Mwakisisile J, et al
Safety and Immunogenicity of Accelerated Heterologous Two-dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa.
Clin Infect Dis. 2024 Apr 24:ciae215. doi: 10.1093.
PubMed Abstract available

HASAN T, Lynch M, King C, Wehbe C, et al
Vaccine-Preventable Disease Outbreaks among Healthcare Workers: A Scoping Review.
Clin Infect Dis. 2024 Apr 17:ciae209. doi: 10.1093.
PubMed Abstract available

Correction to: Discordant Antibody and T-Cell Responses to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019 Messenger RNA Vaccine Recipients.
Clin Infect Dis. 2024 Apr 15:ciae165. doi: 10.1093.
PubMed

SHERMAN A, Tuan J, Cantos VD, Adeyiga O, et al
COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials.
Clin Infect Dis. 2024 Apr 10:ciae192. doi: 10.1093.
PubMed Abstract available

FAHERTY EAG, Holly T, Ogale YP, Spencer H, et al
Investigation of an mpox outbreak affecting many vaccinated persons in Chicago, IL-March 2023-June 2023.
Clin Infect Dis. 2024 Apr 3:ciae181. doi: 10.1093.
PubMed Abstract available

SU WJ, Chen HL, Chen SF, Liu YL, et al
Optimization of Mother-to-Child Hepatitis B Virus Prevention Program: Integration of Maternal Screening and Infant Post-vaccination Serologic Testing.
Clin Infect Dis. 2024 Apr 2:ciae176. doi: 10.1093.
PubMed Abstract available

March 2024

ROSTAD CA, Atmar RL, Walter EB, Frey S, et al
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03 Adjuvant in Healthy US
Clin Infect Dis. 2024 Mar 27:ciae173. doi: 10.1093.
PubMed Abstract available

PINEDA-PENA AC, Jiang Q, Petit C, Korejwo-Peyramond J, et al
Immunogenicity and Safety of a Purified Vero Rabies Vaccine - Serum Free, Compared With Two Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized Controlled Phase III Trial.
Clin Infect Dis. 2024 Mar 13:ciae137. doi: 10.1093.
PubMed Abstract available

SHRESTHA NK, Burke PC, Nowacki AS, Gordon SM, et al
Effectiveness of the 2023-2024 Formulation of the Coronavirus Disease 2019 mRNA Vaccine.
Clin Infect Dis. 2024 Mar 11:ciae132. doi: 10.1093.
PubMed Abstract available

ROMINE JK, Li H, Coughlin MM, Jones JM, et al
Hybrid immunity and SARS-CoV-2 antibodies: results of the HEROES-RECOVER prospective cohort study.
Clin Infect Dis. 2024 Mar 11:ciae130. doi: 10.1093.
PubMed Abstract available

February 2024

SHAH MM, Joyce B, Plumb ID, Sahakian S, et al
Combined protection of vaccination and nirmatrelvir-ritonavir against hospitalization in adults with COVID-19.
Clin Infect Dis. 2024 Feb 27:ciae105. doi: 10.1093.
PubMed Abstract available

FOLLMANN D, Mateja A, Fay MP, Magaret CA, et al
Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine.
Clin Infect Dis. 2024 Feb 19:ciae081. doi: 10.1093.
PubMed Abstract available

TOEPFER AP, Amarin JZ, Spieker AJ, Stewart LS, et al
Seasonality, clinical characteristics, and outcomes of respiratory syncytial virus disease by subtype among children less than five years old, New Vaccine Surveillance Network, United States, 2016-2020.
Clin Infect Dis. 2024 Feb 15:ciae085. doi: 10.1093.
PubMed Abstract available

HOFMEYER KA, Ventura CL, Armstrong KL, Houchens CR, et al
Project NexGen: Developing the Next Generation of COVID-19 Vaccines and Therapeutics to Respond to the Present and Prepare for the Future.
Clin Infect Dis. 2024 Feb 13:ciae073. doi: 10.1093.
PubMed Abstract available

MCCONEGHY KW, Hur K, Dahabreh IJ, Jiang R, et al
Early Mortality After the First Dose of Coronavirus Disease 2019 Vaccination: A Target Trial Emulation.
Clin Infect Dis. 2024 Feb 6:ciad604. doi: 10.1093.
PubMed Abstract available

January 2024

GROV C, Zohra F, Mirzayi C, Stief M, et al
Sexual and Gender Minorities' Vaccine Uptake and Behavioral Change in Response to the Mpox Outbreak in the United States: August 2022 Through November 2022.
Clin Infect Dis. 2024 Jan 23:ciad793. doi: 10.1093.
PubMed Abstract available

ISON MG, Papi A, Athan E, Feldman RG, et al
Efficacy and safety of respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over 2 RSV seasons.
Clin Infect Dis. 2024 Jan 22:ciae010. doi: 10.1093.
PubMed Abstract available

CHANDLER R, Montenegro N, Llorach C, Aguirre LN, et al
Immunogenicity, Reactogenicity, and Safety of AS01E-adjuvanted RSV Prefusion F Protein-based Candidate Vaccine (RSVPreF3 OA) When Co-administered With a Seasonal Quadrivalent Influenza Vaccine in Older Adults: Results of a Phase 3, Open-Label, Randomi
Clin Infect Dis. 2024 Jan 8:ciad786. doi: 10.1093.
PubMed Abstract available

December 2023

TADESSE BT, Keddy KH, Rickett NY, Zhusupbekova A, et al
Vaccination to Reduce Antimicrobial Resistance Burden-Data Gaps and Future Research.
Clin Infect Dis. 2023;77.
PubMed Abstract available

KOW CS, Ramachandram DS, Hasan SS, Thiruchelvam K, et al
COVID-19 Vaccination: Safeguarding Against Post-COVID Cardiovascular Complications.
Clin Infect Dis. 2023 Dec 6:ciad732. doi: 10.1093.
PubMed

RYBAK A, Assad Z, Levy C, Bonarcorsi S, et al
Age-specific resurgence in invasive pneumococcal disease incidence in the COVID-19 pandemic era and its association with respiratory virus and pneumococcal carriage dynamics: a time series analysis.
Clin Infect Dis. 2023 Dec 6:ciad746. doi: 10.1093.
PubMed Abstract available

LEWIS NM, Zhu Y, Peltan ID, Gaglani M, et al
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.
Clin Infect Dis. 2023 Dec 5:ciad677. doi: 10.1093.
PubMed Abstract available

November 2023

MOGHADAS SM, Shoukat A, Bawden CE, Langley JM, et al
Cost-effectiveness of Prefusion F Protein-based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States.
Clin Infect Dis. 2023 Nov 30:ciad658. doi: 10.1093.
PubMed Abstract available

USDAN L, Patel S, Rodriguez H, Xu X, et al
A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in >/=12-Year-Olds.
Clin Infect Dis. 2023 Nov 28:ciad718. doi: 10.1093.
PubMed Abstract available

LEE N, Nguyen L, Austin PC, Brown KA, et al
Protection conferred by COVID-19 vaccination, prior SARS-CoV-2 infection, or hybrid immunity against Omicron-associated severe outcomes among community-dwelling adults.
Clin Infect Dis. 2023 Nov 24:ciad716. doi: 10.1093.
PubMed Abstract available

ATHAN E, Baber J, Quan K, Scott RJ, et al
Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Older Adults.
Clin Infect Dis. 2023 Nov 22:ciad707. doi: 10.1093.
PubMed Abstract available

ADAMS K, Weber ZA, Yang DH, Klein NP, et al
Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season, VISION Network.
Clin Infect Dis. 2023 Nov 16:ciad704. doi: 10.1093.
PubMed Abstract available

LEE AW, Liu K, Lhomme E, Blie J, et al
Immunogenicity and vaccine shedding after 1 or 2 doses of rVZVDeltaG-ZEBOV-GP Ebola vaccine (ERVEBO(R)): Results from a phase 2, randomized, placebo-controlled trial in children and adults.
Clin Infect Dis. 2023 Nov 15:ciad693. doi: 10.1093.
PubMed Abstract available

TIPPETT A, Ess G, Hussaini L, Reese O, et al
Influenza Vaccine Effectiveness Pre-pandemic among Adults Hospitalized with Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, and Older Adults.
Clin Infect Dis. 2023 Nov 8:ciad679. doi: 10.1093.
PubMed Abstract available

October 2023

FONTAN-VELA M, Hernando V, Olmedo C, Coma E, et al
Effectiveness of MVA-BN vaccination in a population at high-risk of mpox: a Spanish cohort study.
Clin Infect Dis. 2023 Oct 21:ciad645. doi: 10.1093.
PubMed Abstract available

CARAZO S, Guay CA, Skowronski DM, Amini R, et al
Influenza hospitalization burden by subtype, age, comorbidity and vaccination status: 2012/13 to 2018/19 seasons, Quebec, Canada.
Clin Infect Dis. 2023 Oct 11:ciad627. doi: 10.1093.
PubMed Abstract available

SCHUSTER JE, Hamdan L, Dulek DE, Kitko CL, et al
The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial.
Clin Infect Dis. 2023 Oct 6:ciad534. doi: 10.1093.
PubMed Abstract available

CONLY JM, Loeb M
SARS-CoV-2 Exposures in a Large Gathering Event and Acquisition of COVID-19 in the Post-Vaccintion Era: A Randomized Trial is Possible During the Pandemic.
Clin Infect Dis. 2023 Oct 5:ciad609. doi: 10.1093.
PubMed

STEINBERG J, Bressler SS, Orell L, Thompson GC, et al
Invasive pneumococcal disease and potential impact of pneumococcal conjugate vaccines among adults, including persons experiencing homelessness - Alaska, 2011-2020.
Clin Infect Dis. 2023 Oct 3:ciad597. doi: 10.1093.
PubMed Abstract available

September 2023

BROUSSEAU N, Carazo S, Febriani Y, Padet L, et al
Single-dose effectiveness of mpox vaccine in Quebec, Canada: test-negative design with and without adjustment for self-reported exposure risk.
Clin Infect Dis. 2023 Sep 28:ciad584. doi: 10.1093.
PubMed Abstract available

LOPEZ BERNAL J, Andrews N, Gower C, Stowe J, et al
Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From Coronavirus Disease 2019 in Adults Aged >/=70 Years.
Clin Infect Dis. 2023 Sep 27:ciab881. doi: 10.1093.
PubMed Abstract available

YANG J, Lo NC, Dankwa EA, Donnelly CA, et al
Determining herd immunity thresholds for hepatitis A virus transmission to inform vaccination strategies among people who inject drugs in 16 U.S. States.
Clin Infect Dis. 2023 Sep 21:ciad552. doi: 10.1093.
PubMed Abstract available

FELDMAN RG, Antonelli-Incalzi R, Steenackers K, Lee DG, et al
Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions.
Clin Infect Dis. 2023 Sep 12:ciad471. doi: 10.1093.
PubMed Abstract available

LAI SW
Comment on Parameswaran et al's "Increased Stroke Risk Following Herpes Zoster Infection and Protection With Zoster Vaccine".
Clin Infect Dis. 2023;77:801-802.
PubMed

August 2023

WONG CKH, Lau KTK, Au ICH, Lau EHY, et al
Comparison of bivalent and monovalent mRNA vaccine boosters.
Clin Infect Dis. 2023 Aug 30:ciad519. doi: 10.1093.
PubMed Abstract available

GRIGGS EP, Mitchell PK, Lazariu V, Gaglani M, et al
Clinical epidemiology and risk factors for critical outcomes among vaccinated and unvaccinated adults hospitalized with COVID-19-VISION Network, 10 States, June 2021-March 2023.
Clin Infect Dis. 2023 Aug 26:ciad505. doi: 10.1093.
PubMed Abstract available

TATE JE, Mwenda JM, Keita AM, Tapsoba TW, et al
Evaluation of Intussusception Following Pentavalent Rotavirus Vaccine (RotaTeq) Administration in Five Countries in Africa.
Clin Infect Dis. 2023 Aug 19:ciad492. doi: 10.1093.
PubMed Abstract available

MOMBELLI M, Neofytos D, Huynh-Do U, Sanchez-Cespedes J, et al
Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients: The STOP-FLU trial.
Clin Infect Dis. 2023 Aug 16:ciad477. doi: 10.1093.
PubMed Abstract available

FELD JJ, Bruneau J, Dore GJ, Ghany MG, et al
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design Considerations.
Clin Infect Dis. 2023;77.
PubMed Abstract available

BILINSKI A, Slimovitch R, Mendlowitz A, Feld JJ, et al
First Do No Harm? Modeling Risks and Benefits of Challenge Trials for Hepatitis C Vaccine Development.
Clin Infect Dis. 2023;77.
PubMed Abstract available

LIANG TJ, Feld JJ, Shoukry NH, Thomas DL, et al
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Is It Time to Be Real?
Clin Infect Dis. 2023;77.
PubMed

July 2023

POZZI C, Sarti R, Levi R, Mollura M, et al
Association between duration of SARS-CoV-2 positivity and long COVID.
Clin Infect Dis. 2023 Jul 22:ciad434. doi: 10.1093.
PubMed Abstract available

MOSCHESE D, Bianchi M, Cossu MV, Salari F, et al
Neutralizing antibody titers induced by JYNNEOS vaccine in unrecognized previous mpox virus exposed individuals.
Clin Infect Dis. 2023 Jul 7:ciad412. doi: 10.1093.
PubMed

MATUSALI G, Mazzotta V, Piselli P, Bettini A, et al
Asymptomatic Mpox infection in subjects presenting for MVA-BN vaccine.
Clin Infect Dis. 2023 Jul 7:ciad414. doi: 10.1093.
PubMed

ITANI O, Hochedez P, Benabdelmoumen G, Jidar K, et al
Antibody titers in elderly patients after rabies post-exposure prophylaxis.
Clin Infect Dis. 2023 Jul 5:ciad408. doi: 10.1093.
PubMed

BAERENDS EAM, Reekie J, Andreasen SR, Staerke NB, et al
Omicron variant-specific serological imprinting following BA.1 or BA.4/5 bivalent vaccination and previous SARS-CoV-2 infection: A cohort study.
Clin Infect Dis. 2023 Jul 1:ciad402. doi: 10.1093.
PubMed Abstract available

June 2023

FAUST JS, Kumar A, Shah J, Khadke S, et al
Oral Nirmatrelvir and Ritonavir for Covid-19 in Vaccinated, Non-Hospitalized Adults, Ages 18-50 Years.
Clin Infect Dis. 2023 Jun 30:ciad400. doi: 10.1093.
PubMed Abstract available

WILCK M, Cornely OA, Cordonnier C, Velez JD, et al
A phase 3 randomized, double-blind, comparator-controlled study to evaluate safety, tolerability and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in allogeneic hematopoietic cell transplant recipients (PNEU-STEM).
Clin Infect Dis. 2023 Jun 20:ciad349. doi: 10.1093.
PubMed Abstract available

AUERSWALD H, Maestri A, Touch S, In S, et al
Side-by-side comparative study of the immunogenicity of the intramuscular and intradermal rabies post-exposure prophylaxis regimens in a cohort of suspected RABV exposed individuals.
Clin Infect Dis. 2023 Jun 20:ciad304. doi: 10.1093.
PubMed Abstract available

UPASANI V, Townsend K, Wu MY, Carr EJ, et al
Commercial immunoglobulin products contain neutralising antibodies against SARS-CoV-2 spike protein.
Clin Infect Dis. 2023 Jun 20:ciad368. doi: 10.1093.
PubMed Abstract available

NAFICY A, Kuxhausen A, Pirrotta P, Leav B, et al
No immunological interference or safety concerns when adjuvanted recombinant zoster vaccine is coadministered with a COVID-19 mRNA-1273 booster vaccine in adults aged 50 years and older: A randomized trial.
Clin Infect Dis. 2023 Jun 19:ciad361. doi: 10.1093.
PubMed Abstract available

WIESE AD, Mitchel E, Ndi D, Markus TM, et al
Risk of Acute Myocardial Infarction Among Patients With Laboratory-Confirmed Invasive Pneumococcal Disease: A Self-Controlled Case Series Study.
Clin Infect Dis. 2023;76:2171-2177.
PubMed Abstract available

LEWNARD JA, Hong V, Bruxvoort KJ, Grant LR, et al
Burden of lower respiratory tract infections preventable by adult immunization with 15- and 20-valent pneumococcal conjugate vaccines in the United States.
Clin Infect Dis. 2023 Jun 9:ciad355. doi: 10.1093.
PubMed Abstract available

May 2023

KOJIMA N, Adams K, Self WH, Gaglani M, et al
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022.
Clin Infect Dis. 2023 May 31:ciad276. doi: 10.1093.
PubMed Abstract available

LUNDGREN J
Patients Hospitalized With Coronavirus Disease 2019: A Diverse Population.
Clin Infect Dis. 2023 May 31:ciad280. doi: 10.1093.
PubMed

Correction to: Relative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination and Booster Dose Combinations Among 18.9 Million Vaccinated Adults During the Early Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Period-Un
Clin Infect Dis. 2023 May 30:ciad256. doi: 10.1093.
PubMed

CHAVES SS, Naeger S, Lounaci K, Zuo Y, et al
High-dose influenza vaccine is associated with reduced mortality among older adults with breakthrough influenza even when there is poor vaccine-strain match.
Clin Infect Dis. 2023 May 29:ciad322. doi: 10.1093.
PubMed Abstract available

ASTURIAS EJ, Excler JL, Ackland J, Cavaleri M, et al
Safety of Streptococcus pyogenes vaccines: Anticipating and Overcoming Challenges for Clinical Trials and Post Marketing Monitoring.
Clin Infect Dis. 2023 May 26:ciad311. doi: 10.1093.
PubMed Abstract available

ZENG G, Zhou Y
Association of virus variation and vaccination status with post-acute sequelae after SARS-cov-2 infection.
Clin Infect Dis. 2023 May 10:ciad292. doi: 10.1093.
PubMed

KO JY, Pham H, Anglin O, Chai SJ, et al
Vaccination Status and Trends in Adult COVID-19-Associated Hospitalizations by Race and Ethnicity, March 2020-August 2022.
Clin Infect Dis. 2023 May 3:ciad266. doi: 10.1093.
PubMed Abstract available

HASSANZADEH H, Baber J, Begier E, Noriega DC, et al
Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STRIVE Randomized Clinical Trial.
Clin Infect Dis. 2023 May 1:ciad218. doi: 10.1093.
PubMed Abstract available

April 2023

PROCTOR RA
Development of a Staphylococcus aureus Vaccine: An On-going Journey.
Clin Infect Dis. 2023 Apr 29:ciad217. doi: 10.1093.
PubMed

DE REZENDE IM, McClure MA, Pereira LS, Fradico JRB, et al
Characterization and investigation of risk factors for Late-relapsing hepatitis after yellow fever.
Clin Infect Dis. 2023 Apr 26:ciad249. doi: 10.1093.
PubMed Abstract available

KASUMBA IN, Badji H, Powell H, Hossain MJ, et al
Shigella in Africa: New Insights From the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
Clin Infect Dis. 2023;76.
PubMed Abstract available

HOSSAIN MJ, Powell H, Sow SO, Omore R, et al
Clinical and Epidemiologic Features of Cryptosporidium-Associated Diarrheal Disease Among Young Children Living in Sub-Saharan Africa: The Vaccine Impact on Diarrhea in Africa (VIDA) Study.
Clin Infect Dis. 2023;76.
PubMed Abstract available

BERENDES DM, Omore R, Prentice-Mott G, Fagerli K, et al
Exploring Survey-Based Water, Sanitation, and Animal Associations With Enteric Pathogen Carriage: Comparing Results in a Cohort of Cases With Moderate-to-Severe Diarrhea to Those in Controls in the Vaccine Impact on Diarrhea in Africa (VIDA) Study, 20
Clin Infect Dis. 2023;76.
PubMed Abstract available

OMORE R, Powell H, Sow SO, Jahangir Hossain M, et al
Norovirus Disease Among Children <5 Years in 3 Sub-Saharan African Countries: Findings From the Vaccine Impact on Diarrhea in Africa (VIDA) Study, 2015-2018.
Clin Infect Dis. 2023;76.
PubMed Abstract available

DEICHSEL EL, Keita AM, Verani JR, Powell H, et al
Management of Diarrhea in Young Children in Sub-Saharan Africa: Adherence to World Health Organization Recommendations During the Global Enteric Multisite Study (2007-2011) and the Vaccine Impact of Diarrhea in Africa (VIDA) Study (2015-2018).
Clin Infect Dis. 2023;76.
PubMed Abstract available

KEITA AM, Doh S, Sow SO, Powell H, et al
Prevalence, Clinical Severity, and Seasonality of Adenovirus 40/41, Astrovirus, Sapovirus, and Rotavirus Among Young Children With Moderate-to-Severe Diarrhea: Results From the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
Clin Infect Dis. 2023;76.
PubMed Abstract available

BERENDES DM, Fagerli K, Kim S, Nasrin D, et al
Survey-Based Assessment of Water, Sanitation, and Animal-Associated Risk Factors for Moderate-to-Severe Diarrhea in the Vaccine Impact on Diarrhea in Africa (VIDA) Study: The Gambia, Mali, and Kenya, 2015-2018.
Clin Infect Dis. 2023;76.
PubMed Abstract available

NASRIN D, Liang Y, Verani JR, Powell H, et al
Stunting Following Moderate-to-Severe Diarrhea Among Children Aged <5 Years in Africa Before and After Rotavirus Vaccine Introduction: A Comparison of the Global Enteric Multicenter Study and the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
Clin Infect Dis. 2023;76.
PubMed Abstract available

BUCHWALD AG, Verani JR, Keita AM, Jahangir Hossain M, et al
Etiology, Presentation, and Risk Factors for Diarrheal Syndromes in 3 Sub-Saharan African Countries After the Introduction of Rotavirus Vaccines From the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
Clin Infect Dis. 2023;76.
PubMed Abstract available

SCHWARTZ LM, Oshinsky J, Reymann M, Esona MD, et al
Histo-Blood Group Antigen Null Phenotypes Associated With a Decreased Risk of Clinical Rotavirus Vaccine Failure Among Children <2 Years of Age Participating in the Vaccine Impact on Diarrhea in Africa (VIDA) Study in Kenya, Mali, and the Gambia.
Clin Infect Dis. 2023;76.
PubMed Abstract available

STEELE AD, Armah GE, Mwenda JM, Kirkwood CD, et al
The Full Impact of Rotavirus Vaccines in Africa Has Yet to Be Realized.
Clin Infect Dis. 2023;76.
PubMed Abstract available

OCHIENG JB, Powell H, Sugerman CE, Omore R, et al
Epidemiology of Enteroaggregative, Enteropathogenic, and Shiga Toxin-Producing Escherichia coli Among Children Aged <5 Years in 3 Countries in Africa, 2015-2018: Vaccine Impact on Diarrhea in Africa (VIDA) Study.
Clin Infect Dis. 2023;76.
PubMed Abstract available

MARCENAC P, Traore A, Kim S, Prentice-Mott G, et al
Giardia Detection and Codetection With Other Enteric Pathogens in Young Children in the Vaccine Impact on Diarrhea in Africa (VIDA) Case-Control Study: 2015-2018.
Clin Infect Dis. 2023;76.
PubMed Abstract available

DEICHSEL EL, Powell H, Troeger C, Hossain MJ, et al
Drivers of Decline in Diarrhea Mortality Between GEMS and VIDA Studies.
Clin Infect Dis. 2023;76.
PubMed Abstract available

NASRIN D, Liang Y, Powell H, Casanova IG, et al
Moderate-to-Severe Diarrhea and Stunting Among Children Younger Than 5 Years: Findings From the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
Clin Infect Dis. 2023;76.
PubMed Abstract available

KASUMBA IN, Powell H, Omore R, Hossain MJ, et al
Prevalence of Salmonella in Stool During the Vaccine Impact on Diarrhea in Africa (VIDA) Study, 2015-2018.
Clin Infect Dis. 2023;76.
PubMed Abstract available

POWELL H, Liang Y, Neuzil KM, Jamka LP, et al
A Description of the Statistical Methods for the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
Clin Infect Dis. 2023;76.
PubMed Abstract available

AWUOR AO, Ogwel B, Powell H, Verani JR, et al
Antibiotic-Prescribing Practices for Management of Childhood Diarrhea in 3 Sub-Saharan African Countries: Findings From the Vaccine Impact on Diarrhea in Africa (VIDA) Study, 2015-2018.
Clin Infect Dis. 2023;76.
PubMed Abstract available

JOFFE AR, Elliott A, Eapen R, Milburn C, et al
Is vaccination acting as a placebo in preventing symptoms of Long-COVID?
Clin Infect Dis. 2023 Apr 19:ciad234. doi: 10.1093.
PubMed

CHEN GJ, Sun HY, Lin KY, Hsieh SM, et al
A randomized clinical trial of one-dose versus accelerated two-dose schedule for hepatitis A virus revaccination among people with HIV who were non-responders or had seroreversion after primary HAV vaccination.
Clin Infect Dis. 2023 Apr 10:ciad206. doi: 10.1093.
PubMed Abstract available

MARKS KM, Kang M, Umbleja T, Avihingsanon A, et al
Immunogenicity and Safety of Hepatitis B vaccine with a Toll-like Receptor 9 Agonist Adjuvant (HEPLISAV-B) in HBV Vaccine-naive People with HIV.
Clin Infect Dis. 2023 Apr 5:ciad201. doi: 10.1093.
PubMed Abstract available

March 2023

MACFADDEN DR, Maxwell C, Bowdish D, Bronskill S, et al
COVID-19 Vaccination is Associated with Reduced Outpatient Antibiotic Prescribing In Older Adults with Confirmed SARS-CoV-2: A Population Wide Cohort Study.
Clin Infect Dis. 2023 Mar 31:ciad190. doi: 10.1093.
PubMed Abstract available

HOLZBAUER SM, Schrodt CA, Prabhu RM, Asch-Kendrick RJ, et al
Fatal Human Rabies Infection with Suspected Host-mediated Failure of Post-Exposure Prophylaxis Following a Recognized Zoonotic Exposure-Minnesota, 2021.
Clin Infect Dis. 2023 Mar 29:ciad098. doi: 10.1093.
PubMed Abstract available

FERREIRA VH, Ierullo M, Mavandadnejad F, Kurtesi A, et al
Omicron BA.4/5 neutralization and T-cell responses in organ transplant recipients after Booster mRNA vaccine: a Multicenter Cohort Study.
Clin Infect Dis. 2023 Mar 28:ciad175. doi: 10.1093.
PubMed Abstract available

ATKINS KE, Hodgson D
Vaccination of older adults against RSV: the final pieces of the puzzle.
Clin Infect Dis. 2023 Mar 23:ciad162. doi: 10.1093.
PubMed

VAN EFFELTERRE T, Hens N, White LJ, Gravenstein S, et al
Modeling Respiratory Syncytial Virus Adult Vaccination in the United States with a Dynamic Transmission Model.
Clin Infect Dis. 2023 Mar 23:ciad161. doi: 10.1093.
PubMed Abstract available

HOFFMAN SA, LeBoa C, Date K, Haldar P, et al
Programmatic Effectiveness of a Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India.
Clin Infect Dis. 2023 Mar 22:ciad132. doi: 10.1093.
PubMed Abstract available

CAREY ME
Gateway to typhoid conjugate vaccine introduction in India and beyond - programmatic effectiveness of a public sector typhoid conjugate vaccine campaign in Navi Mumbai.
Clin Infect Dis. 2023 Mar 22:ciad134. doi: 10.1093.
PubMed

CHUNG H, Campitelli MA, Buchan SA, Campigotto A, et al
Evaluating the impact of statin use on influenza vaccine effectiveness and influenza infection in older adults.
Clin Infect Dis. 2023 Mar 21:ciad148. doi: 10.1093.
PubMed Abstract available

Correction to: Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada.
Clin Infect Dis. 2023 Mar 15:ciac607. doi: 10.1093.
PubMed

OGALE YP, Baird N, Townsend MB, Berry I, et al
Evidence of mpox virus infection among persons without characteristic lesions or rash presenting for first dose of JYNNEOS vaccine-District of Columbia, August 2022.
Clin Infect Dis. 2023 Mar 14:ciad145. doi: 10.1093.
PubMed Abstract available

Correction to: Duration of Protection After Vaccination Against Yellow Fever - Systematic Review and Meta-analysis.
Clin Infect Dis. 2023 Mar 11:ciac822. doi: 10.1093.
PubMed

KAHLERT CR, Strahm C, Gusewell S, Cusini A, et al
Post-acute sequelae after SARS-CoV-2 infection by viral variant and vaccination status: a multicenter cross-sectional study.
Clin Infect Dis. 2023 Mar 11:ciad143. doi: 10.1093.
PubMed Abstract available

NIRENBERG E, Perencevich EN
Understanding and Improving Vaccine Effectiveness Estimates in the Age of Widespread Background Immunity: A Step Towards Improved Science Communication.
Clin Infect Dis. 2023 Mar 8:ciad124. doi: 10.1093.
PubMed Abstract available

STABLER S, Lamblin C, Gaillard S, Just N, et al
High Frequency of Specific Polysaccharide Antibody Deficiency in Adults With Unexplained, Recurrent and/or Severe Infections With Encapsulated Bacteria.
Clin Infect Dis. 2023;76:800-808.
PubMed Abstract available

LEA AN, Leyden WA, Sofrygin O, Marafino BJ, et al
Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 (COVID-19) Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout.
Clin Infect Dis. 2023 Mar 2:ciad084. doi: 10.1093.
PubMed Abstract available

IMP BM, Levine T, Satre DD, Skarbinski J, et al
Influenza Vaccination Uptake and Associated Factors Among Adults With and Without HIV in a Large, Integrated Health Care System.
Clin Infect Dis. 2023 Mar 1:ciad106. doi: 10.1093.
PubMed Abstract available

Correction to: Effectiveness of Messenger RNA-based Vaccines During the Emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant.
Clin Infect Dis. 2023 Mar 1:ciac810. doi: 10.1093.
PubMed

February 2023

Correction to: Coronavirus Disease 2019 [COVID-19] Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Matching Study.
Clin Infect Dis. 2023 Feb 8:ciac632. doi: 10.1093.
PubMed

KOMPANIYETS L, Wiegand RE, Oyalowo AC, Bull-Otterson L, et al
Relative effectiveness of COVID-19 vaccination and booster dose combinations among 18.9 million vaccinated adults during the early SARS-CoV-2 Omicron period - United States, January 1, 2022-March 31, 2022.
Clin Infect Dis. 2023 Feb 8:ciad063. doi: 10.1093.
PubMed Abstract available

HOY G, Kuan G, Lopez R, Sanchez N, et al
The Spectrum of Influenza in Children.
Clin Infect Dis. 2023;76:e1012-e1020.
PubMed Abstract available

AMIRTHALINGAM G, Campbell H, Ribeiro S, Stowe J, et al
Optimization of Timing of Maternal Pertussis Immunization From 6 Years of Postimplementation Surveillance Data in England.
Clin Infect Dis. 2023;76:e1129-e1139.
PubMed Abstract available

SCHULTE J, Short K, Persse D
Management and Control Issues Related to Two Mumps Outbreaks in Houston: Future Implications.
Clin Infect Dis. 2023;76:e1416-e1420.
PubMed Abstract available

MAIER HE, Kuan G, Gresh L, Chowell G, et al
The Nicaraguan Pediatric Influenza Cohort Study, 2011-2019: Influenza Incidence, Seasonality, and Transmission.
Clin Infect Dis. 2023;76:e1094-e1103.
PubMed Abstract available

January 2023

MELICA G, Bartolucci P, Audureau E, Le Corvoisier P, et al
Immunological efficacy of pneumococcal vaccination including the 13-valent pneumococcal vaccine in adult patients with sickle-cell disease: results of the randomized DREVAC controlled trial.
Clin Infect Dis. 2023 Jan 27:ciad037. doi: 10.1093.
PubMed Abstract available

Correction to: Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada.
Clin Infect Dis. 2023 Jan 18:ciac584. doi: 10.1093.
PubMed

BONAZZETTI C, Tazza B, Gibertoni D, Pasquini Z, et al
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort.
Clin Infect Dis. 2023 Jan 13:ciad016. doi: 10.1093.
PubMed Abstract available

Correction to: Prevention of Neisseria gonorrhoeae With Meningococcal B Vaccine: A Matched Cohort Study in Southern California.
Clin Infect Dis. 2023 Jan 11:ciac936. doi: 10.1093.
PubMed

Correction to: Longitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer.
Clin Infect Dis. 2023 Jan 6:ciac964. doi: 10.1093.
PubMed

DALTON AF, Weber ZA, Allen KS, Stenehjem E, et al
Relationships between social vulnerability and COVID-19 vaccination coverage and vaccine effectiveness.
Clin Infect Dis. 2023 Jan 6:ciad003. doi: 10.1093.
PubMed Abstract available

TITANJI BK
The Last Mile Problem - COVID-19 Vaccine Coverage Among the Most Socially Vulnerable.
Clin Infect Dis. 2023 Jan 6:ciad006. doi: 10.1093.
PubMed

WINOKUR PL, Hegmann TE, Keitel WA, Bernstein DI, et al
Safety and Immunogenicity of a monovalent inactivated influenza A/H5N8 virus vaccine given with and without AS03 or MF59 adjuvants in healthy adults.
Clin Infect Dis. 2023 Jan 5:ciac983. doi: 10.1093.
PubMed Abstract available

NEUZIL KM, Anderson EJ, Frenck RW, Frey SE, et al
Safety and Immunogenicity of Influenza A/H5N8 Virus Vaccine in Healthy Adults: Durability and Cross-reactivity of Antibody Responses.
Clin Infect Dis. 2023 Jan 5:ciac982. doi: 10.1093.
PubMed Abstract available

Correction to: Anogenital Human Papillomavirus (HPV) Infection, Seroprevalence, and Risk Factors for HPV Seropositivity Among Sexually Active Men Enrolled in a Global HPV Vaccine Trial.
Clin Infect Dis. 2023 Jan 4:ciac768. doi: 10.1093.
PubMed

December 2022

HERRING MK, Romine JK, Wesley MG, Ellingson KD, et al
SARS-CoV-2 infection history and antibody response to three COVID-19 mRNA vaccine doses.
Clin Infect Dis. 2022 Dec 29:ciac976. doi: 10.1093.
PubMed Abstract available

THET AK, Kelly PJ, Kasule SN, Shah AK, et al
The use of vaccinia immune globulin in the treatment of severe mpox virus infection in HIV/AIDS.
Clin Infect Dis. 2022 Dec 26:ciac971. doi: 10.1093.
PubMed Abstract available

ROBINSON ML, Morris CP, Betz JF, Zhang Y, et al
Impact of SARS-CoV-2 variants on inpatient clinical outcome.
Clin Infect Dis. 2022 Dec 19:ciac957. doi: 10.1093.
PubMed Abstract available

NEHME M, Vetter P, Chappuis F, Kaiser L, et al
Prevalence of post-COVID Condition 12 Weeks after Omicron Infection Compared to Negative Controls and Association with Vaccination Status.
Clin Infect Dis. 2022 Dec 15:ciac947. doi: 10.1093.
PubMed Abstract available

PRICE AM, Flannery B, Talbot HK, Grijalva CG, et al
Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season.
Clin Infect Dis. 2022 Dec 12:ciac941. doi: 10.1093.
PubMed Abstract available

PRUNAS O, Weinberger DM, Pitzer VE, Gazit S, et al
Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents in Israel.
Clin Infect Dis. 2022 Dec 9:ciac315. doi: 10.1093.
PubMed Abstract available

EDWARDS KM, Neuzil KM
Developing mucosal vaccines for SARS-CoV-2: What will it take?
Clin Infect Dis. 2022 Dec 9:ciac935. doi: 10.1093.
PubMed

COHEN JI, Dropulic L, Wang K, Gangler K, et al
Comparison of levels of nasal, salivary, and plasma antibody to SARS-CoV-2 during natural infection and after vaccination.
Clin Infect Dis. 2022 Dec 9:ciac934. doi: 10.1093.
PubMed Abstract available

November 2022

TADESSE BT, Bravo L, Marks F, Aziz AB, et al
Impact of vaccination with SCB-2019 COVID-19 vaccine on transmission of SARS-CoV-2 infection: a household contact study in the Philippines.
Clin Infect Dis. 2022 Nov 26:ciac914. doi: 10.1093.
PubMed Abstract available

LEVIN MJ, Ustianowski A, Thomas S, Templeton A, et al
AZD7442 (Tixagevimab/Cilgavimab) for Post-exposure Prophylaxis of Symptomatic COVID-19.
Clin Infect Dis. 2022 Nov 22:ciac899. doi: 10.1093.
PubMed Abstract available

MARTIN C, Dauby N
Guiding yellow fever vaccination strategy worldwide: booster = better?
Clin Infect Dis. 2022 Nov 16. pii: 6830230. doi: 10.1093.
PubMed

SHAH MM, Spencer BR, Feldstein LR, Haynes JM, et al
Occupations Associated with SARS-CoV-2 Infection and Vaccination, U.S. Blood Donors, July 2021-December 2021.
Clin Infect Dis. 2022 Nov 14. pii: 6825618. doi: 10.1093.
PubMed Abstract available

BARDA N, Canetti M, Gilboa M, Asraf K, et al
The Association Between Pre-Booster Vaccination Antibody Levels and the Risk of SARS-CoV-2 Infection.
Clin Infect Dis. 2022 Nov 11. pii: 6821340. doi: 10.1093.
PubMed Abstract available

BLOSSEY AM, Bruckner S, May M, Parzmair GP, et al
VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including COVID-19 in the Elderly: a phase III randomised, double-blind, placebo-controlled, multicenter clinical study.
Clin Infect Dis. 2022 Nov 11. pii: 6821343. doi: 10.1093.
PubMed Abstract available

OTERO S, Miller ES, Sunderraj A, Shanes ED, et al
Maternal Antibody Response and Transplacental Transfer Following SARS-CoV-2 Infection or Vaccination in Pregnancy.
Clin Infect Dis. 2022 Nov 9. pii: 6812657. doi: 10.1093.
PubMed Abstract available

SIEGHART D, Hana CA, Haslacher H, Perkmann T, et al
MULTI-PARAMETRIC PREDICTION MODELS FOR COVID-19 VACCINE SELECTION: RESULTS OF A COMPARATIVE POPULATION-BASED COHORT STUDY.
Clin Infect Dis. 2022 Nov 4. pii: 6795267. doi: 10.1093.
PubMed Abstract available

TENFORDE MW, Patel MM, Lewis NM, Adams K, et al
Vaccine effectiveness against influenza A(H3N2)-associated hospitalized illness, United States, 2022.
Clin Infect Dis. 2022 Nov 3. pii: 6795261. doi: 10.1093.
PubMed Abstract available

October 2022

BETTINGER JA, Irvine MA, Shulha HP, Valiquette L, et al
Adverse Events Following Immunization with mRNA and Viral Vector Vaccines in Individuals with Previous SARS-CoV-2 Infection from the Canadian National Vaccine Safety Network.
Clin Infect Dis. 2022 Oct 31. pii: 6780916. doi: 10.1093.
PubMed Abstract available

ASARE K, Andine T, Naicker N, Dorward J, et al
Impact of point-of-care testing on the management of sexually transmitted infections in South Africa: Evidence from the HVTN702 HIV vaccine trial.
Clin Infect Dis. 2022 Oct 15. pii: 6761890. doi: 10.1093.
PubMed Abstract available

MALOSH RE, McGovern I, Monto AS
Influenza During the 2010-2020 Decade in the United States: Seasonal Outbreaks and Vaccine Interventions.
Clin Infect Dis. 2022 Oct 11. pii: 6758391. doi: 10.1093.
PubMed Abstract available

HEATH PT, Galiza EP, Baxter DN, Boffito M, et al
Safety and Efficacy of the NVX-CoV2373 COVID-19 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.
Clin Infect Dis. 2022 Oct 10. pii: 6754597. doi: 10.1093.
PubMed Abstract available

BISWAL S, Patel SS, Rauscher M
Safety of Dengue Vaccine?
Clin Infect Dis. 2022 Oct 5. pii: 6748245. doi: 10.1093.
PubMed

FIDLER S, Fox J, Tipoe T, Longet S, et al
Booster vaccination against SARS-CoV-2 induces potent immune responses in people with HIV.
Clin Infect Dis. 2022 Oct 5. pii: 6748267. doi: 10.1093.
PubMed Abstract available

September 2022

ISLAM MT, Date K, Khan AI, Bhuiyan TR, et al
Co-administration of Oral Cholera Vaccine with Oral Polio Vaccine among Bangladeshi Young Children: A Randomized Controlled Open Label Trial to Assess Interference.
Clin Infect Dis. 2022 Sep 22. pii: 6711550. doi: 10.1093.
PubMed Abstract available

FLOREA A, Sy LS, Qian L, Ackerson BK, et al
Effectiveness of mRNA-1273 vaccine booster against COVID-19 in immunocompetent adults.
Clin Infect Dis. 2022 Sep 22. pii: 6711079. doi: 10.1093.
PubMed Abstract available

SIANGPHOE U, Baden LR, El Sahly HM, Essink B, et al
Associations of Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA-1273 Vaccine in COVE and TeenCOVE Trials.
Clin Infect Dis. 2022 Sep 20. pii: 6708263. doi: 10.1093.
PubMed Abstract available

NAJJAR-DEBBINY R, Gronich N, Weber G, Khoury J, et al
Effectiveness of Molnupiravir in High Risk Patients: a Propensity Score Matched Analysis.
Clin Infect Dis. 2022 Sep 20. pii: 6708264. doi: 10.1093.
PubMed Abstract available

ONO S, Michihata N, Yamana H, Uemura K, et al
Comparative effectiveness of BNT162b2 and mRNA-1273 booster dose after BNT162b2 primary vaccination against the Omicron variants: A retrospective cohort study using large-scale population-based registries in Japan.
Clin Infect Dis. 2022 Sep 18. pii: 6696997. doi: 10.1093.
PubMed Abstract available

BOULWARE DR, Murray TA, Proper JL, Tignanelli CJ, et al
Impact of SARS-CoV-2 vaccination and booster on COVID-19 symptom severity over time in the COVID-OUT trial.
Clin Infect Dis. 2022 Sep 17. pii: 6702474. doi: 10.1093.
PubMed Abstract available

HSU CK, Lai CC
The confounding effect of vaccine status.
Clin Infect Dis. 2022 Sep 16. pii: 6701809. doi: 10.1093.
PubMed

TURNER P, Sa-Leao R, Greenhill A, Leach A, et al
World Health Organization (WHO) Standard Methods for Pneumococcal Carriage Studies.
Clin Infect Dis. 2022;75:924-925.
PubMed

MAGNUS MC, Haberg SE, Carlsen EO, Kwong JC, et al
Pregnancy status at the time of COVID-19 vaccination and incidence of SARS-CoV-2 infection.
Clin Infect Dis. 2022 Sep 8. pii: 6693880. doi: 10.1093.
PubMed Abstract available

NIKAS A, Ahmed H, Zarnitsyna VI
Estimating Waning of Vaccine Effectiveness: a Simulation Study.
Clin Infect Dis. 2022 Sep 3. pii: 6691361. doi: 10.1093.
PubMed Abstract available

VAN DIJCK C, Hens N, Kenyon C, Tsoumanis A, et al
The roles of unrecognized monkeypox cases, contact isolation and vaccination in determining epidemic size in Belgium. A modelling study.
Clin Infect Dis. 2022 Sep 2. pii: 6686539. doi: 10.1093.
PubMed Abstract available

DE SILVA A
Safety of Dengue Vaccine?
Clin Infect Dis. 2022 Sep 1. pii: 6681127. doi: 10.1093.
PubMed

August 2022

MATHIS AD, Clemmons NS, Redd SB, Pham H, et al
Maintenance of Measles Elimination Status in the United States for 20 Years Despite Increasing Challenges.
Clin Infect Dis. 2022;75:416-424.
PubMed Abstract available

ORIJE MRP, Garcia-Fogeda I, Van Dyck W, Corbiere V, et al
Impact of Maternal Pertussis Antibodies on the Infants' Cellular Immune Responses.
Clin Infect Dis. 2022;75:442-452.
PubMed Abstract available

WIRTH KE, Edwards JK, Feinstein L, Breskin A, et al
When emulating a trial, do as the trialists do: Missteps in estimating relative effectiveness of a SARS-CoV-2 vaccine booster dose.
Clin Infect Dis. 2022 Aug 30. pii: 6679241. doi: 10.1093.
PubMed

GAGLANI M, Kim SS, Naleway AL, Levine MZ, et al
Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial.
Clin Infect Dis. 2022 Aug 29. pii: 6678123. doi: 10.1093.
PubMed Abstract available

AMIN AB, Tate JE, Waller LA, Lash TL, et al
Monovalent rotavirus vaccine efficacy against different rotavirus genotypes: a pooled analysis of Phase II and III trial data.
Clin Infect Dis. 2022 Aug 29. pii: 6678127. doi: 10.1093.
PubMed Abstract available

BANERJEE E, Paul P, Griffith J, Laine E, et al
Impact of Isolation and Exclusion as a Public Health Strategy to Contain Measles Virus Transmission During a Measles Outbreak.
Clin Infect Dis. 2022;75:152-154.
PubMed Abstract available

ANDREJKO K, Ratnasiri B, Lewnard JA
Association of Pneumococcal Serotype With Susceptibility to Antimicrobial Drugs: A Systematic Review and Meta-analysis.
Clin Infect Dis. 2022;75:131-140.
PubMed Abstract available

GANATRA S, Dani SS, Ahmad J, Kumar A, et al
Oral Nirmatrelvir and Ritonavir in Non-hospitalized Vaccinated Patients with Covid-19.
Clin Infect Dis. 2022 Aug 20. pii: 6672670. doi: 10.1093.
PubMed Abstract available

NASREEN S, Febriani Y, Velasquez Garcia HA, Zhang G, et al
Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: A multiprovincial test-negative design study.
Clin Infect Dis. 2022 Aug 17. pii: 6668859. doi: 10.1093.
PubMed Abstract available

KARABA AH, Zhou W, Li S, Aytenfisu TY, et al
Impact of Seasonal Coronavirus Antibodies on SARS-CoV-2 Vaccine Responses in Solid Organ Transplant Recipients.
Clin Infect Dis. 2022 Aug 12. pii: 6663288. doi: 10.1093.
PubMed Abstract available

PECK H, Anbumurali N, McMahon K, Freeman K, et al
Detection of influenza in managed quarantine in Australia and the estimated risk of importation.
Clin Infect Dis. 2022 Aug 12. pii: 6663754. doi: 10.1093.
PubMed Abstract available

ZAMBRANO LD, Newhams MM, Olson SM, Halasa NB, et al
BNT162b2 mRNA Vaccination Against COVID-19 is Associated with Decreased Likelihood of Multisystem Inflammatory Syndrome in U.S. Children Ages 5-18 Years.
Clin Infect Dis. 2022 Aug 4. pii: 6655523. doi: 10.1093.
PubMed Abstract available

PRAY IW, Grajewski B, Morris C, Modji K, et al
Measuring work-related risk of COVID-19: comparison of COVID-19 incidence by occupation and industry - Wisconsin, September 2020-May 2021.
Clin Infect Dis. 2022 Aug 4. pii: 6655522. doi: 10.1093.
PubMed Abstract available

ARASHIRO T, Arima Y, Muraoka H, Sato A, et al
COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection during Delta-dominant and Omicron-dominant periods in Japan: a multi-center prospective case-control study (FASCINATE study).
Clin Infect Dis. 2022 Aug 3. pii: 6653543. doi: 10.1093.
PubMed Abstract available

July 2022

LEHRNBECHER T, Sack U, Speckmann C, Groll AH, et al
Longitudinal Immune Response to Three Doses of mRNA Vaccine Against COVID-19 in Pediatric Patients Receiving Chemotherapy for Cancer.
Clin Infect Dis. 2022 Jul 28. pii: 6651274. doi: 10.1093.
PubMed Abstract available

ESPARCIA-PINEDO L, Yarci-Carrion A, Mateo-Jimenez G, Ropero N, et al
Development of an effective immune response in adults with Down Syndrome after SARS-CoV-2 vaccination.
Clin Infect Dis. 2022 Jul 23. pii: 6649074. doi: 10.1093.
PubMed Abstract available

SAHNI LC, Naioti EA, Olson SM, Campbell AP, et al
Sustained within-season vaccine effectiveness against influenza-associated hospitalization in children: Evidence from the New Vaccine Surveillance Network, 2015-2016 through 2019-2020.
Clin Infect Dis. 2022 Jul 22. pii: 6648556. doi: 10.1093.
PubMed Abstract available

KLING K, Domingo C, Bogdan C, Duffy S, et al
Duration of protection after vaccination against yellow fever - systematic review and meta-analysis.
Clin Infect Dis. 2022 Jul 20. pii: 6646957. doi: 10.1093.
PubMed Abstract available

HATFIELD KM, Baggs J, Wolford H, Fang M, et al
Effectiveness of COVID-19 vaccination against SARS-CoV-2 Infection among Residents of US Nursing Homes, Before and During the Delta variant Predominance, December 2020 - November 2021.
Clin Infect Dis. 2022 Jul 20. pii: 6646955. doi: 10.1093.
PubMed Abstract available

PARAMESWARAN GI, Wattengel BA, Chua HC, Swiderek J, et al
Increased Stroke Risk Following Herpes Zoster Infection and Protection with Zoster Vaccine.
Clin Infect Dis. 2022 Jul 7. pii: 6633277. doi: 10.1093.
PubMed Abstract available

SANDERS JSF, Lianne Messchendorp A, de Vries RD, Baan CC, et al
Antibody and T-cell responses 6 months after COVID-19 mRNA-1273 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant.
Clin Infect Dis. 2022 Jul 7. pii: 6633280. doi: 10.1093.
PubMed Abstract available

TURNER AN, Carter AM, Tzeng YL, Stephens DS, et al
Infection With the US Neisseria meningitidis Urethritis Clade Does Not Lower Future Risk of Urethral Gonorrhea.
Clin Infect Dis. 2022;74:2159-2165.
PubMed Abstract available

MURISON KR, Grima AA, Simmons AE, Tuite AR, et al
Severity of SARS-CoV-2 Infection in Pregnancy in Ontario: A Matched Cohort Analysis.
Clin Infect Dis. 2022 Jul 6. pii: 6632524. doi: 10.1093.
PubMed Abstract available

GRANT LR, Slack MPE, Theilacker C, Vojicic J, et al
Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children from High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination.
Clin Infect Dis. 2022 Jul 5. pii: 6629370. doi: 10.1093.
PubMed Abstract available

June 2022

GOOD MK, Czarnik M, Harmon KG, Aukerman D, et al
SARS-CoV-2 Infections and Reinfections among Fully Vaccinated and Unvaccinated University Athletes - 15 States, January - November 2021.
Clin Infect Dis. 2022 Jun 30. pii: 6623463. doi: 10.1093.
PubMed Abstract available

GLATMAN-FREEDMAN A, Feldman SF, Hershkovitz Y, Kaufman Z, et al
Vaccine coverage associated with ending a SARS-CoV-2 wave: a retrospective longitudinal analysis.
Clin Infect Dis. 2022 Jun 28. pii: 6619125. doi: 10.1093.
PubMed Abstract available

MOLINE HL, Keaton A, Rice W, Varghese J, et al
Effectiveness of COVID-19 mRNA vaccines against infection during an outbreak of SARS-CoV-2 Beta (B.1.351) variant in a skilled nursing facility - Virginia, March-April 2021.
Clin Infect Dis. 2022 Jun 27. pii: 6618595. doi: 10.1093.
PubMed Abstract available

OH DY, Holzer M, Paraskevopoulou S, Trofimova M, et al
Advancing Precision Vaccinology by Molecular and Genomic Surveillance of SARS-CoV-2 in Germany, 2021.
Clin Infect Dis. 2022 Jun 25. pii: 6617635. doi: 10.1093.
PubMed Abstract available

IDOKO OT, Usuf E, Okomo U, Wonodi C, et al
SARS-CoV-2 in Africa: current considerations and future projections.
Clin Infect Dis. 2022 Jun 25. pii: 6617636. doi: 10.1093.
PubMed Abstract available

KUTTY PK, Stuckey MJ, Koumans EH
Vaccines, Variants, and Vigilance: Strengthening the COVID-19 Public Health Response through Partnerships and Collaborations.
Clin Infect Dis. 2022 Jun 24. pii: 6617337. doi: 10.1093.
PubMed Abstract available

CHOI D, Nielsen J, Waller LA, Patel SA, et al
The US COVID-19 surveillance environment: An ecological analysis of the relationship of testing adequacy in the context of vaccination.
Clin Infect Dis. 2022 Jun 24. pii: 6617111. doi: 10.1093.
PubMed Abstract available

PLOTKIN SA
Why We Need Precision Vaccinology.
Clin Infect Dis. 2022 Jun 23. pii: 6615391. doi: 10.1093.
PubMed

MORROCCHI E, Pighi C, Pascucci GR, Cotugno N, et al
Perinatally HIV-infected adolescents and young adults demonstrate distinct BNT162b2 mRNA COVID-19 vaccine immunogenicity.
Clin Infect Dis. 2022 Jun 23. pii: 6615389. doi: 10.1093.
PubMed Abstract available

OHLSEN EC, Yankey D, Pezzi C, Kriss JL, et al
COVID-19 vaccination coverage, intentions, attitudes and barriers by race/ethnicity, language of interview, and nativity, National Immunization Survey Adult COVID Module, April 22, 2021-January 29, 2022.
Clin Infect Dis. 2022 Jun 23. pii: 6614630. doi: 10.1093.
PubMed Abstract available

BROSH-NISSIMOV T, Hussein K, Wiener-Well Y, Orenbuch-Harroch E, et al
Hospitalized patients with severe COVID-19 during the Omicron wave in Israel - benefits of a fourth vaccine dose.
Clin Infect Dis. 2022 Jun 20. pii: 6611845. doi: 10.1093.
PubMed Abstract available

ROSKOSKY M, Moni G, Kawakami V, Lambert J, et al
SARS-CoV-2 Transmission Associated with an Indoor Music Event That Required Proof of Full Vaccination Against COVID-19 Prior to Entry-Seattle, July 2021.
Clin Infect Dis. 2022 Jun 20. pii: 6611550. doi: 10.1093.
PubMed Abstract available

VU DM, Vu DTB, Do TTT, Olmsted AE, et al
Presence of SARS-CoV-2 Antibodies among Vietnamese Healthcare Workers by Dosing Interval for ChAdOx1 nCoV-19 Vaccine.
Clin Infect Dis. 2022 Jun 20. pii: 6611567. doi: 10.1093.
PubMed Abstract available

SABLEROLLES RSG, Rietdijk WJR, Goorhuis A, Postma DF, et al
Durability of immune responses after boosting in Ad26.COV2.S-primed healthcare workers.
Clin Infect Dis. 2022 Jun 20. pii: 6611568. doi: 10.1093.
PubMed Abstract available

KLAASSEN F, Chitwood MH, Cohen T, Pitzer VE, et al
Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021.
Clin Infect Dis. 2022 Jun 20. pii: 6611479. doi: 10.1093.
PubMed Abstract available

RICHARDSON VL, Franco MAC, Marquez AB, Valdez LM, et al
Vaccine effectiveness of CanSino (Adv5-nCoV) COVID-19 vaccine among childcare workers - Mexico, March-December 2021.
Clin Infect Dis. 2022 Jun 19. pii: 6611492. doi: 10.1093.
PubMed Abstract available

ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Vorontsov O, et al
Kinetics of maternally-derived anti- SARS-CoV-2 antibodies in infants in relation to the timing of antenatal vaccination.
Clin Infect Dis. 2022 Jun 19. pii: 6611486. doi: 10.1093.
PubMed Abstract available

CARRIM M, Tempia S, Thindwa D, Martinson NA, et al
Unmasking pneumococcal carriage in a high HIV prevalence population in two community cohorts with a high prevalence of HIV in South Africa, 2016-2018: the PHIRST study.
Clin Infect Dis. 2022 Jun 19. pii: 6611495. doi: 10.1093.
PubMed Abstract available

MONGE S, Rojas-Benedicto A, Olmedo C, Martin-Merino E, et al
Effectiveness of a second dose of an mRNA vaccine against SARS-CoV-2 Omicron infection in individuals previously infected by other variants.
Clin Infect Dis. 2022 Jun 10. pii: 6605647. doi: 10.1093.
PubMed Abstract available

LIM SY, Park S, Kim JY, Kim S, et al
Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural SARS-CoV-2 Infection (With/Without subsequent COVID-19 Vaccination) Versus 2-dose COVID-19 Vaccination.
Clin Infect Dis. 2022 Jun 10. pii: 6605068. doi: 10.1093.
PubMed Abstract available

RUHLAND A, Fell A, Holzbauer SM, D'Heilly P, et al
Exposure Outcomes in Fully Vaccinated Healthcare Personnel with Known SARS-CoV-2 Exposure-Minnesota, January-August 2021.
Clin Infect Dis. 2022 Jun 10. pii: 6605065. doi: 10.1093.
PubMed Abstract available

BUSCH MP, Stramer SL, Stone M, Yu EA, et al
Population-weighted seroprevalence from SARS-CoV-2 infection, vaccination, and hybrid immunity among U.S. blood donations from January-December 2021.
Clin Infect Dis. 2022 Jun 10. pii: 6605072. doi: 10.1093.
PubMed Abstract available

LI ZN, Liu F, Jefferson S, Horner L, et al
Multiplex Detection of Antibody Landscapes to SARS-CoV-2/Influenza/Common Human Coronaviruses Following Vaccination or Infection with SARS-CoV-2 and Influenza.
Clin Infect Dis. 2022 Jun 10. pii: 6605070. doi: 10.1093.
PubMed Abstract available

TOP KA, Chen RT, Levy O, Ozonoff A, et al
Advancing the Science of Vaccine Safety during the COVID-19 Pandemic and Beyond: Launching an International Network of Special Immunization Services.
Clin Infect Dis. 2022 Jun 9. pii: 6605049. doi: 10.1093.
PubMed Abstract available

WAN EYF, Chui CSL, Ng VWS, Wang Y, et al
mRNA (BNT162b2) COVID-19 vaccination increased risk of Bell's palsy: a nested case control and self-controlled case series study.
Clin Infect Dis. 2022 Jun 8. pii: 6604461. doi: 10.1093.
PubMed Abstract available

BART SM, Curtiss CC, Earnest R, Lobe-Costonis R, et al
SARS-CoV-2 Outbreak at a College with High COVID-19 Vaccination Coverage-Connecticut, August-September 2021.
Clin Infect Dis. 2022 Jun 8. pii: 6604453. doi: 10.1093.
PubMed Abstract available

LEWIS NM, Self WH, Gaglani M, Ginde AA, et al
Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
Clin Infect Dis. 2022 Jun 8. pii: 6604454. doi: 10.1093.
PubMed Abstract available

LEUNG NHL, Cheng SMS, Martin-Sanchez M, Au NYM, et al
Immunogenicity of a third dose of BNT162b2 to ancestral SARS-CoV-2 & Omicron variant in adults who received two doses of inactivated vaccine.
Clin Infect Dis. 2022 Jun 8. pii: 6604400. doi: 10.1093.
PubMed Abstract available

NACHEGA JB, Sam-Agudu NA, Siedner MJ, Rosenthal PJ, et al
Prioritizing Pregnant Women for Coronavirus Disease 2019 Vaccination in African Countries.
Clin Infect Dis. 2022 Jun 8. pii: 6603568. doi: 10.1093.
PubMed Abstract available

NACHEGA JB, Sam-Agudu NA, Machekano RN, Rosenthal PJ, et al
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Pregnancy in Sub-Saharan Africa: A 6-Country Retrospective Cohort Analysis.
Clin Infect Dis. 2022 Jun 8. pii: 6603567. doi: 10.1093.
PubMed Abstract available

RICHTERMAN A, Behrman A, Brennan PJ, O'Donnell JA, et al
Durability of SARS-CoV-2 mRNA Booster Vaccine Protection Against Omicron Among Health Care Workers with a Vaccine Mandate.
Clin Infect Dis. 2022 Jun 6. pii: 6603294. doi: 10.1093.
PubMed Abstract available

STRAUS W, Urdaneta V, Esposito DB, Mansi JA, et al
Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide.
Clin Infect Dis. 2022 Jun 6. pii: 6603291. doi: 10.1093.
PubMed Abstract available

NAJJAR-DEBBINY R, Gronich N, Weber G, Khoury J, et al
Effectiveness of Paxlovid in Reducing Severe COVID-19 and Mortality in High Risk Patients.
Clin Infect Dis. 2022 Jun 2. pii: 6599020. doi: 10.1093.
PubMed Abstract available

BRUXVOORT KJ, Lewnard JA, Chen LH, Tseng HF, et al
Prevention of Neisseria gonorrhoeae with meningococcal B vaccine: a matched cohort study in Southern California.
Clin Infect Dis. 2022 Jun 1. pii: 6596517. doi: 10.1093.
PubMed Abstract available

HAVERS FP, Skoff TH, Rench MA, Epperson M, et al
Maternal Tdap Vaccination during Pregnancy: Impact on Infant Anti-pertussis Antibody Concentrations by Maternal Pertussis Priming Series.
Clin Infect Dis. 2022 Jun 1. pii: 6596516. doi: 10.1093.
PubMed Abstract available

May 2022

ISHOLA D
Asymptomatic Malaria Infection and the Immune Response to the 2-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children.
Clin Infect Dis. 2022 May 30. pii: 6595436. doi: 10.1093.
PubMed Abstract available

ANGLEMYER A, McNeill A, DuBray K, Sonder GJB, et al
Invasive Pneumococcal Disease: Concerning Trends in Serotype 19A Notifications in New Zealand.
Clin Infect Dis. 2022;74:1859-1861.
PubMed Abstract available

MEIRING S, Tempia S, Dominic EM, de Gouveia L, et al
Excess Invasive Meningococcal Disease Associated With Seasonal Influenza, South Africa, 2003-2018.
Clin Infect Dis. 2022;74:1729-1735.
PubMed Abstract available

MARRA AR, Miraglia JL, Malheiros DT, Guozhang Y, et al
Effectiveness of heterologous COVID-19 vaccine booster dosing in Brazilian healthcare workers, 2021.
Clin Infect Dis. 2022 May 27. pii: 6594056. doi: 10.1093.
PubMed Abstract available

PATEL SS, Rauscher M, Kudela M, Pang H, et al
Clinical Safety Experience of TAK-003 for Dengue Fever: a new Tetravalent Live Attenuated Vaccine Candidate.
Clin Infect Dis. 2022 May 26. pii: 6593313. doi: 10.1093.
PubMed Abstract available

ZHAO M, Slotkin R, Sheth AH, Pischel L, et al
Serum Neutralizing Antibody Titers 12 months after COVID-19 mRNA Vaccination: Correlation to Clinical Variables in an Adult, US-Population.
Clin Infect Dis. 2022 May 26. pii: 6593314. doi: 10.1093.
PubMed Abstract available

PETROS BA, Turcinovic J, Welch NL, White LF, et al
Early introduction and rise of the Omicron SARS-CoV-2 variant in highly vaccinated university populations.
Clin Infect Dis. 2022 May 25. pii: 6591846. doi: 10.1093.
PubMed Abstract available

GRIMA AA, Murison KR, Simmons AE, Tuite AR, et al
Relative Virulence of SARS-CoV-2 Among Vaccinated and Unvaccinated Individuals Hospitalized with SARS-CoV-2.
Clin Infect Dis. 2022 May 25. pii: 6591845. doi: 10.1093.
PubMed Abstract available

EPSI NJ, Richard SA, Lindholm DA, Mende K, et al
Understanding 'hybrid immunity': comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines.
Clin Infect Dis. 2022 May 24. pii: 6591282. doi: 10.1093.
PubMed Abstract available

CORRADINI P, Agrati C, Apolone G, Mantovani A, et al
Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study.
Clin Infect Dis. 2022 May 24. pii: 6590993. doi: 10.1093.
PubMed Abstract available

LOFGREN E, Naumova EN, Gorski J, Naumov Y, et al
How drivers of seasonality in respiratory infections may impact vaccine strategy: a case study in how COVID-19 may help us solve one of influenza's biggest challenges.
Clin Infect Dis. 2022 May 24. pii: 6590989. doi: 10.1093.
PubMed Abstract available

EYAL N, Gheaus A, Gosseries A, Magalhaes M, et al
COVID vaccine prioritization in low- and middle-income countries may justifiably depart from high-income countries' age priorities.
Clin Infect Dis. 2022 May 24. pii: 6590988. doi: 10.1093.
PubMed Abstract available

LAGOUSI T, Papadatou I, Strempas P, Chatzikalil E, et al
PAVING THE WAY TOWARDS PRECISION VACCINOLOGY: THE PARADIGM OF MYOCARDITIS AFTER COVID-19 VACCINATION.
Clin Infect Dis. 2022 May 24. pii: 6590985. doi: 10.1093.
PubMed Abstract available

SHAPIRO JR, Sitaras I, Park HS, Aytenfisu TY, et al
Association of frailty, age, and biological sex with SARS-CoV-2 mRNA vaccine-induced immunity in older adults.
Clin Infect Dis. 2022 May 24. pii: 6590987. doi: 10.1093.
PubMed Abstract available

ROTTENSTREICH A, Vorontsov O, Alfi O, Zarbiv G, et al
Maternal and Neonatal SARS-CoV-2 Omicron Variant Neutralization after Antenatal mRNA Vaccination.
Clin Infect Dis. 2022 May 24. pii: 6590984. doi: 10.1093.
PubMed Abstract available

LEVIN-RECTOR A, Firestein L, McGibbon E, Sell J, et al
Reduced Odds of SARS-CoV-2 Reinfection after Vaccination among New York City Adults, July-November 2021.
Clin Infect Dis. 2022 May 20. pii: 6589783. doi: 10.1093.
PubMed Abstract available

TENFORDE MW, Self WH, Zhu Y, Naioti EA, et al
Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States.
Clin Infect Dis. 2022 May 17. pii: 6587132. doi: 10.1093.
PubMed Abstract available

MARTINUZZI E, Benzaquen J, Guerin O, Leroy S, et al
A Single Dose of BNT162b2 mRNA Vaccine Induces Airway Immunity in SARS-CoV-2 Naive and recovered COVID-19 subjects.
Clin Infect Dis. 2022 May 17. pii: 6586846. doi: 10.1093.
PubMed Abstract available

WEITZMAN ER, Kossowsky J, Blakemore LM, Cox R, et al
Acceptability of a Fentanyl Vaccine to Prevent Opioid Overdose and Need for Personalized Decision-Making.
Clin Infect Dis. 2022 May 17. pii: 6586840. doi: 10.1093.
PubMed Abstract available

WEITZMAN ER, Sherman AC, Levy O
Pediatric SARS-CoV-2 Vaccines: Perceptions and Attitudes from the FDA Public Commentary.
Clin Infect Dis. 2022 May 17. pii: 6586838. doi: 10.1093.
PubMed Abstract available

BARI A, Heymann M, Cohen RJ, Zhao R, et al
Exploring Coronavirus Disease 2019 Vaccine Hesitancy on Twitter Using Sentiment Analysis and Natural Language Processing Algorithms.
Clin Infect Dis. 2022;74.
PubMed Abstract available

POH XY, Tan CW, Lee IR, Chavatte JM, et al
Antibody response of heterologous vs homologous mRNA vaccine boosters against the SARS-CoV-2 Omicron variant: interim results from the PRIBIVAC study, A Randomized Clinical Trial.
Clin Infect Dis. 2022 May 11. pii: 6583615. doi: 10.1093.
PubMed Abstract available

CONTI MG, Terreri S, Terrin G, Natale F, et al
SARS-CoV-2 infection versus vaccination in pregnancy: Implications for maternal and infant immunity.
Clin Infect Dis. 2022 May 10. pii: 6583148. doi: 10.1093.
PubMed Abstract available

SPARKE M, Levy O
Competing responses to global inequalities in access to COVID vaccines: Vaccine Diplomacy and Vaccine Charity Versus Vaccine Liberty.
Clin Infect Dis. 2022 May 10. pii: 6583150. doi: 10.1093.
PubMed Abstract available

ZURCHER K, Abela IA, Stange M, Dupont C, et al
Alpha variant coronavirus outbreak in a nursing home despite high vaccination coverage: molecular, epidemiological and immunological studies.
Clin Infect Dis. 2022 May 6. pii: 6582009. doi: 10.1093/cid/ciab1005.
PubMed Abstract available

DOWLING DJ, Levy O
A Precision Adjuvant Approach to Enhance SARS-CoV-2 Vaccines Optimized for Immunologically Distinct Vulnerable Populations.
Clin Infect Dis. 2022 May 4. pii: 6580093. doi: 10.1093.
PubMed Abstract available

BUTT AA, Talisa VB, Shaikh OS, Omer SB, et al
Relative Vaccine Effectiveness of a SARS-CoV-2 mRNA Vaccine Booster Dose Against the Omicron Variant.
Clin Infect Dis. 2022 May 3. pii: 6577096. doi: 10.1093.
PubMed Abstract available

BEN-SHIMOL S, Regev-Yochay G, Givon-Lavi N, van der Beek BA, et al
Dynamics of Invasive Pneumococcal Disease in Israel in Children and Adults in the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Era: A Nationwide Prospective Surveillance.
Clin Infect Dis. 2022;74:1639-1649.
PubMed Abstract available

April 2022

CHOW EPF, Fairley CK, Zou H, Wigan R, et al
Correction to: Human Papillomavirus Antibody Levels Following Vaccination or Natural Infection Among Young Men Who Have Sex With Men.
Clin Infect Dis. 2022 Apr 27. pii: 6574995. doi: 10.1093.
PubMed

BUSKERMOLEN M, Molthof I, Voeten HA, van Twillert J, et al
Vaccination did not prevent severe COVID in an outbreak among older residents of a nursing home, B.1.617.2 variant, July 2021.
Clin Infect Dis. 2022 Apr 27. pii: 6574733. doi: 10.1093.
PubMed

SHRESTHA NK, Shrestha P, Burke PC, Nowacki AS, et al
Coronavirus Disease 2019 (COVID-19) Vaccine Boosting in Previously Infected or Vaccinated Individuals.
Clin Infect Dis. 2022 Apr 27. pii: 6574819. doi: 10.1093.
PubMed Abstract available

SHARMA A, Oda G, Holodniy M
Effectiveness of mRNA-based vaccines during the emergence of SARS-CoV-2 Omicron variant.
Clin Infect Dis. 2022 Apr 27. pii: 6574744. doi: 10.1093.
PubMed Abstract available

SOLERA JT, Arbol BG, Alshahrani A, Bahinskaya I, et al
Impact of Vaccination and Early Monoclonal Antibody Therapy on COVID-19 Outcomes in Organ Transplant Recipients During the Omicron Wave.
Clin Infect Dis. 2022 Apr 21. pii: 6571785. doi: 10.1093.
PubMed Abstract available

ZAHRA FT, Grubbs G, Dummer K, Tremoulet AH, et al
Neutralization of SARS-CoV-2 Omicron and other variants in serum from children with vaccination-induced myocarditis.
Clin Infect Dis. 2022 Apr 21. pii: 6571576. doi: 10.1093.
PubMed Abstract available

DAN J, da Silva Antunes R, Grifoni A, Weiskopf D, et al
Observations and perspectives on adaptive immunity to SARS-CoV-2.
Clin Infect Dis. 2022 Apr 20. pii: 6571103. doi: 10.1093.
PubMed Abstract available

KIM J, Choe YJ, Jang EJ, Lim DS, et al
Effectiveness of Booster mRNA Vaccines against SARS-CoV-2 Infection in Elderly Population, South Korea, October 2021 - January 2022.
Clin Infect Dis. 2022 Apr 19. pii: 6570782. doi: 10.1093.
PubMed

NANISHI E, Angelidou A, Rotman C, Dowling DJ, et al
Precision Vaccine Adjuvants for Older Adults: A Scoping Review.
Clin Infect Dis. 2022 Apr 19. pii: 6570880. doi: 10.1093.
PubMed Abstract available

LEVY O, Angelidou A, Idoko O, Lewis NP, et al
Precision Vaccines: Lessons Learned from the Coronavirus Pandemic.
Clin Infect Dis. 2022 Apr 19. pii: 6570826. doi: 10.1093.
PubMed

WOLDEMESKEL BA, Garliss CC, Aytenfisu TY, Johnston TS, et al
Discordant antibody and T cell responses to the SARS-CoV-2 Omicron variant in COVID-19 mRNA vaccine recipient.
Clin Infect Dis. 2022 Apr 19. pii: 6570698. doi: 10.1093.
PubMed Abstract available

SKOWRONSKI DM, Febriani Y, Ouakki M, Setayeshgar S, et al
Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada.
Clin Infect Dis. 2022 Apr 19. pii: 6570607. doi: 10.1093.
PubMed Abstract available

MAEDA H, Saito N, Igarashi A, Ishida M, et al
Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the Delta variant epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS).
Clin Infect Dis. 2022 Apr 19. pii: 6570603. doi: 10.1093.
PubMed Abstract available

MOORE HC, Cannon JW, Kaslow DC, Lamagni T, et al
A systematic framework for prioritising burden of disease data required for vaccine development and implementation: the case for group A streptococcal diseases.
Clin Infect Dis. 2022 Apr 19. pii: 6570502. doi: 10.1093.
PubMed Abstract available

PLUMMER JT, Contreras D, Zhang W, Binek A, et al
USA SARS-CoV-2 Epsilon Variant: Though Highly Transmissible has an Adjusted Muted Host T-Cell Response.
Clin Infect Dis. 2022 Apr 19. pii: 6570676. doi: 10.1093.
PubMed Abstract available

LARSEN HK, Kjaer SK, Haedersdal M, Kjaer AK, et al
Anal human papillomavirus infection in kidney transplant recipients compared with immunocompetent controls.
Clin Infect Dis. 2022 Apr 19. pii: 6570488. doi: 10.1093.
PubMed Abstract available

SHERMAN AC, Rouphael N, Baden LR
COVID-19 Vaccine Trials (and Tribulations): How to improve the process of clinical trials in a pandemic.
Clin Infect Dis. 2022 Apr 18. pii: 6569988. doi: 10.1093.
PubMed Abstract available

DALE AP, Almendares O, Howard B, Burnett E, et al
Investigation of A SARS-CoV-2 Delta (B.1.617.2) Variant Outbreak Among Residents of a Skilled Nursing Facility and Vaccine Effectiveness Analysis - Maricopa County, Arizona, June-July 2021.
Clin Infect Dis. 2022 Apr 12. pii: 6567536. doi: 10.1093.
PubMed Abstract available

PREMIKHA M, Chiew CJ, Wei WE, Leo YS, et al
Comparative Effectiveness of mRNA and Inactivated Whole Virus Vaccines against COVID-19 Infection and Severe Disease in Singapore.
Clin Infect Dis. 2022 Apr 12. pii: 6567428. doi: 10.1093.
PubMed Abstract available

TADESSE BT, Khanam F, Ahmed F, Im J, et al
Prevention of typhoid by Vi conjugate vaccine and achievable improvements in household WASH: Evidence from a cluster-randomized trial in Dhaka, Bangladesh.
Clin Infect Dis. 2022 Apr 12. pii: 6567455. doi: 10.1093.
PubMed Abstract available

RZYMSKI P, Falfushynska H, Fal A
Vaccination of Ukrainian Refugees: Need for Urgent Action.
Clin Infect Dis. 2022 Apr 11. pii: 6569707. doi: 10.1093.
PubMed Abstract available

GAZIT S, Shlezinger R, Perez G, Lotan R, et al
SARS-CoV-2 Naturally Acquired Immunity vs. Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: a Retrospective Cohort Study.
Clin Infect Dis. 2022 Apr 5. pii: 6563799. doi: 10.1093.
PubMed Abstract available

ANTINORI A, Cicalini S, Meschi S, Bordoni V, et al
Humoral and cellular immune response elicited by mRNA vaccination against SARS-CoV-2 in people living with HIV (PLWH) receiving antiretroviral therapy (ART) according with current CD4 T-lymphocyte count.
Clin Infect Dis. 2022 Apr 2. pii: 6562777. doi: 10.1093.
PubMed Abstract available

March 2022

DOLL MK, Pettigrew SM, Ma J, Verma A, et al
Effects of Confounding Bias in COVID-19 and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors.
Clin Infect Dis. 2022 Mar 24. pii: 6553950. doi: 10.1093.
PubMed Abstract available

NG OT, Koh V, Chiew CJ, Marimuthu K, et al
Impact of SARS-CoV-2 Vaccination and Paediatric Age on Delta Variant Household Transmission.
Clin Infect Dis. 2022 Mar 22. pii: 6551710. doi: 10.1093.
PubMed Abstract available

GIMENEZ E, Albert E, Zulaica J, Torres I, et al
SARS-CoV-2 adaptive immunity in nursing home residents following a third dose of the Comirnaty(R) COVID-19 vaccine.
Clin Infect Dis. 2022 Mar 21. pii: 6551700. doi: 10.1093.
PubMed Abstract available

GALLAGHER KME, Leick MB, Larson RC, Berger TR, et al
Differential T cell immunity to SARS-CoV-2 in mRNA-1273 and BNT162b2 vaccinated individuals.
Clin Infect Dis. 2022 Mar 12. pii: 6547848. doi: 10.1093.
PubMed Abstract available

RIFE MAGALIS B, Rich S, Tagliamonte MS, Mavian C, et al
SARS-CoV-2 Delta vaccine breakthrough transmissibility in Alachua County, Florida.
Clin Infect Dis. 2022 Mar 10. pii: 6546683. doi: 10.1093.
PubMed Abstract available

BALCELLS ME, Le Corre N, Duran J, Ceballos ME, et al
Reduced immune response to inactivated SARS-CoV-2 vaccine in a cohort of immunocompromised patients in Chile.
Clin Infect Dis. 2022 Mar 7. pii: 6543937. doi: 10.1093.
PubMed Abstract available

MOORLAG SJCFM, Taks E, Ten Doesschate T, van der Vaart TW, et al
Efficacy of Bacillus Calmette-Guerin vaccination against respiratory tract infections in the elderly during the Covid-19 pandemic.
Clin Infect Dis. 2022 Mar 5. pii: 6543010. doi: 10.1093.
PubMed Abstract available

POLLOCK BD, Storlie CB, Tande AJ, Sampathkumar P, et al
Real-world incidence of breakthrough COVID-19 hospitalization after vaccination versus natural infection in a large, local, empaneled primary care population using time-to-event analysis.
Clin Infect Dis. 2022 Mar 5. pii: 6542971. doi: 10.1093.
PubMed Abstract available

BUTT AA, Talisa VB, Yan P, Shaikh OS, et al
Vaccine Effectiveness of Three vs. Two Doses of SARS-CoV-2 mRNA Vaccines in a High Risk National Population.
Clin Infect Dis. 2022 Mar 4. pii: 6542712. doi: 10.1093.
PubMed Abstract available

SPEICH B, Chammartin F, Abela IA, Amico P, et al
Antibody response in immunocompromised patients after the administration of SARS-CoV-2 vaccine BNT162b2 or mRNA-1273: A randomised controlled trial.
Clin Infect Dis. 2022 Mar 2. pii: 6540899. doi: 10.1093.
PubMed Abstract available

GANDHI M
Immunity Against the Omicron Variant from Vaccination, Recovery or Both.
Clin Infect Dis. 2022 Mar 2. pii: 6540839. doi: 10.1093.
PubMed

February 2022

BERENDSEN MLT, Silva I, Bale C, Nielsen S, et al
The effect of a second dose of measles vaccine at 18 months of age on non-accidental deaths and hospital admissions in Guinea-Bissau: interim analysis of a randomized controlled trial.
Clin Infect Dis. 2022 Feb 26. pii: 6537530. doi: 10.1093.
PubMed Abstract available

HAIDAR G, Agha M, Bilderback A, Lukanski A, et al
Prospective evaluation of COVID-19 vaccine responses across a broad spectrum of immunocompromising conditions: the COVICS study.
Clin Infect Dis. 2022 Feb 18. pii: 6530582. doi: 10.1093.
PubMed Abstract available

LI C, Ye Z, Zhang AJ, Chan JF, et al
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections by intranasal or testicular inoculation induces testicular damage preventable by vaccination in golden Syrian hamsters.
Clin Infect Dis. 2022 Feb 18. pii: 6530400. doi: 10.1093.
PubMed Abstract available

BECERRA-CULQUI TA, Getahun D, Chiu V, Sy LS, et al
Prenatal influenza vaccination or influenza infection and autism spectrum disorder in offspring.
Clin Infect Dis. 2022 Feb 17. pii: 6528744. doi: 10.1093.
PubMed Abstract available

ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Vorontsov O, et al
The effect of gestational age at BNT162b2 mRNA vaccination on maternal and neonatal SARS-CoV-2 antibody levels.
Clin Infect Dis. 2022 Feb 16. pii: 6529520. doi: 10.1093.
PubMed Abstract available

GAO DX, Fisher LD, Miller DR, Geller AC, et al
Inequities in COVID-19 vaccination rates among adolescents in Massachusetts: a cross-sectional study.
Clin Infect Dis. 2022 Feb 13. pii: 6527834. doi: 10.1093.
PubMed Abstract available

HEININGER U
Diphtheria, Tetanus, and Pertussis: Unequal Vaccine Siblings With Distinct Characteristics.
Clin Infect Dis. 2022;74:562-563.
PubMed

CONTOPOULOS-IOANNIDIS DG, Altamirano J, Maldonado Y
Infectious Diseases-Related Hospitalizations During Oral Polio Vaccine(OPV) and non-OPV immunization periods: An Empirical Evaluation of all Hospital Discharges in California(1985-2010).
Clin Infect Dis. 2022 Feb 9. pii: 6525447. doi: 10.1093.
PubMed Abstract available

BUTT AA, Talisa VB, Yan P, Shaikh OS, et al
Real-world Effectiveness of the SARS-CoV-2 mRNA Vaccines in Preventing Confirmed Infection in Patients on Chronic Hemodialysis.
Clin Infect Dis. 2022 Feb 9. pii: 6525466. doi: 10.1093.
PubMed Abstract available

RISK M, Shen C, Hayek SS, Holevinski L, et al
Comparative Effectiveness of COVID-19 Vaccines against the Delta Variant.
Clin Infect Dis. 2022 Feb 7. pii: 6523819. doi: 10.1093.
PubMed Abstract available

DRAWZ PE, DeSilva M, Bodurtha P, Benitez GV, et al
Effectiveness of BNT162b2 and mRNA-1273 Second Doses and Boosters for SARS-CoV-2 infection and SARS-CoV-2 Related Hospitalizations: A Statewide Report from the Minnesota Electronic Health Record Consortium.
Clin Infect Dis. 2022 Feb 7. pii: 6523820. doi: 10.1093.
PubMed Abstract available

PERNICIARO S, van der Linden M, Weinberger DM
Re-emergence of Invasive Pneumococcal Disease in Germany during the Spring and Summer of 2021.
Clin Infect Dis. 2022 Feb 7. pii: 6523816. doi: 10.1093.
PubMed Abstract available

HELMSDAL G, Hansen OK, Moller LF, Christiansen DH, et al
Omicron outbreak at a private gathering in the Faroe Islands, infecting 21 of 33 triple-vaccinated healthcare workers.
Clin Infect Dis. 2022 Feb 3. pii: 6520882. doi: 10.1093.
PubMed Abstract available

ONG SWX, Sutjipto S, Lee PH, Dugan C, et al
Validation of ISARIC 4C mortality and deterioration scores in a mixed vaccination status cohort of hospitalized COVID-19 patients in Singapore.
Clin Infect Dis. 2022 Feb 3. pii: 6520952. doi: 10.1093.
PubMed Abstract available

PISCHEL L, Patel KM, Goshua G, Omer SB, et al
Adenovirus-based vaccines and thrombosis in pregnancy: A systematic review and meta-analysis.
Clin Infect Dis. 2022 Feb 2. pii: 6520532. doi: 10.1093.
PubMed Abstract available

NOUSHAD M, Al-Awar MS, Al-Saqqaf IS, Nassani MZ, et al
Lack of access to COVID-19 vaccines could be a greater threat than vaccine hesitancy in low-income and conflict nations: the case of Yemen.
Clin Infect Dis. 2022 Feb 2. pii: 6520556. doi: 10.1093.
PubMed Abstract available

CROMER D, Reynaldi A, Steain M, Triccas JA, et al
Relating in vitro neutralisation level and protection in the CVnCoV (CUREVAC) trial.
Clin Infect Dis. 2022 Feb 1. pii: 6518223. doi: 10.1093.
PubMed Abstract available

January 2022

HOLMDAHL I, Kahn R, Slifka KJ, Dooling K, et al
Modeling the impact of vaccination strategies for nursing homes in the context of increased SARS-CoV-2 community transmission and variants.
Clin Infect Dis. 2022 Jan 29. pii: 6517371. doi: 10.1093.
PubMed Abstract available

WATKINS LKF, Mitruka K, Dorough L, Bressler SS, et al
Characteristics of Reported Deaths Among Fully Vaccinated Persons with COVID-19 -United States, January-April 2021.
Clin Infect Dis. 2022 Jan 29. pii: 6517385. doi: 10.1093.
PubMed Abstract available

MAERTENS K, Orije MRP, Herzog SA, Mahieu LM, et al
Pertussis Immunization During Pregnancy: Assessment of the Role of Maternal Antibodies on Immune Responses in Term and Preterm-Born Infants.
Clin Infect Dis. 2022;74:189-198.
PubMed Abstract available

SPAULDING AC, Zawitz C
Vaccination in Prisons and Jails: Corrections Needed in Future Plans.
Clin Infect Dis. 2022 Jan 27. pii: 6515673. doi: 10.1093/cid/ciab1031.
PubMed

CHIN ET, Leidner D, Zhang Y, Long E, et al
Effectiveness of COVID-19 vaccines among incarcerated people in California state prisons: retrospective cohort study.
Clin Infect Dis. 2022 Jan 27. pii: 6515675. doi: 10.1093/cid/ciab1032.
PubMed Abstract available

LAWRENZ J, Xie Q, Zech F, Weil T, et al
SARS-CoV-2 Vaccination boosts Neutralizing Activity against Seasonal Human Coronaviruses.
Clin Infect Dis. 2022 Jan 25. pii: 6515378. doi: 10.1093.
PubMed Abstract available

LIU J, Laurie MT, Rubio L, Vazquez SE, et al
SARS-CoV-2 transmission dynamics and immune responses in a household of vaccinated persons.
Clin Infect Dis. 2022 Jan 17. pii: 6509064. doi: 10.1093.
PubMed Abstract available

MUSSI-PINHATA MM, Ward S, Laimon L, Pelton SI, et al
Effect of Maternal Vaccination of PCV-10, PPV-23 or Placebo on the Immunogenicity of PCV-10 in HIV-exposed Uninfected Infants: A Randomized Clinical Trial.
Clin Infect Dis. 2022 Jan 17. pii: 6509061. doi: 10.1093.
PubMed Abstract available

SHRESTHA NK, Burke PC, Nowacki AS, Terpeluk P, et al
Necessity of COVID-19 Vaccination in Persons Who Have Already Had COVID-19.
Clin Infect Dis. 2022 Jan 13. pii: 6507165. doi: 10.1093.
PubMed Abstract available

OLSON SM, Newhams MM, Halasa NB, Feldstein LR, et al
Vaccine Effectiveness Against Life-Threatening Influenza Illness in US Children.
Clin Infect Dis. 2022 Jan 13. pii: 6506316. doi: 10.1093.
PubMed Abstract available

HEFTDAL LD, Schultz M, Lange T, Knudsen AD, et al
Incidence of positive SARS-CoV-2 PCR after COVID-19 vaccination with up to eight months of follow-up: Real life data from the Capital Region of Denmark.
Clin Infect Dis. 2022 Jan 7. pii: 6500168. doi: 10.1093.
PubMed Abstract available

LI X, Chan JM, Lam B, Lung DC, et al
COVID-19 mRNA vaccines delay the onset of breakthrough infections with less radiographic abnormalities.
Clin Infect Dis. 2022 Jan 4. pii: 6497432. doi: 10.1093/cid/ciab1062.
PubMed Abstract available

December 2021

CHOW EPF, Fairley CK, Zou H, Wigan R, et al
Human papillomavirus antibody levels following vaccination or natural infection among young men who have sex with men.
Clin Infect Dis. 2021 Dec 31. pii: 6491220. doi: 10.1093/cid/ciab1052.
PubMed Abstract available

LEWNARD JA, Bruxvoort KJ, Fischer H, Hong VX, et al
Effectiveness of 13-valent pneumococcal conjugate vaccine against medically-attended lower respiratory tract infection and pneumonia among older adults.
Clin Infect Dis. 2021 Dec 30. pii: 6490150. doi: 10.1093/cid/ciab1051.
PubMed Abstract available

YAMAMOTO S, Maeda K, Matsuda K, Tanaka A, et al
COVID-19 breakthrough infection and post-vaccination neutralizing antibody among healthcare workers in a referral hospital in Tokyo: a case-control matching study.
Clin Infect Dis. 2021 Dec 24. pii: 6482345. doi: 10.1093/cid/ciab1048.
PubMed Abstract available

ESSINK B, Sabharwal C, Cannon K, Frenck R, et al
Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults 18 Years and Older.
Clin Infect Dis. 2021 Dec 23. pii: 6481672. doi: 10.1093.
PubMed Abstract available

DAGAN R, Van Der Beek BA, Ben-Shimol S, Pilishvili T, et al
Corrigendum to: Effectiveness of the 7- and 13-Valent Pneumococcal Conjugate Vaccines Against Vaccine-Serotype Otitis Media.
Clin Infect Dis. 2021 Dec 21. pii: 6472232. doi: 10.1093.
PubMed

SACHDEV DD, Chew Ng R, Sankaran M, Ernst A, et al
Contact tracing outcomes among household contacts of fully vaccinated COVID-19 patients - San Francisco, California, January 29-July 2, 2021.
Clin Infect Dis. 2021 Dec 20. pii: 6470866. doi: 10.1093/cid/ciab1042.
PubMed Abstract available

TYNER HL, Burgess JL, Grant L, Gaglani M, et al
Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of SARS-CoV-2 Infection.
Clin Infect Dis. 2021 Dec 20. pii: 6470720. doi: 10.1093/cid/ciab1038.
PubMed Abstract available

LUO CH, Morris CP, Sachithanandham J, Amadi A, et al
Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Recovery of Infectious Virus Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals.
Clin Infect Dis. 2021 Dec 18. pii: 6469786. doi: 10.1093.
PubMed Abstract available

LU L, Mok BW, Chen LL, Chan JM, et al
Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients.
Clin Infect Dis. 2021 Dec 16. pii: 6463504. doi: 10.1093/cid/ciab1041.
PubMed Abstract available

DANINO D, Ben-Shimol S, Van Der Beek BA, Givon-Lavi N, et al
Decline in Pneumococcal Disease in Young Children during the COVID-19 Pandemic in Israel Associated with Suppression of seasonal Respiratory Viruses, despite Persistent Pneumococcal Carriage: A Prospective Cohort Study.
Clin Infect Dis. 2021 Dec 14. pii: 6460745. doi: 10.1093/cid/ciab1014.
PubMed Abstract available

SAGARA I, Zongo I, Cairns M, Yerbanga RS, et al
The Anti-Circumsporozoite Antibody Response Of Children To Seasonal Vaccination With The Rts,S/As01e Malaria Vaccine.
Clin Infect Dis. 2021 Dec 11. pii: 6459764. doi: 10.1093/cid/ciab1017.
PubMed Abstract available

BART SM, Harizaj A, Pearson CL, Conteh T, et al
SARS-CoV-2 Delta outbreak among fully vaccinated nursing home residents likely initiated by a fully vaccinated staff member - Connecticut, July-August 2021.
Clin Infect Dis. 2021 Dec 10. pii: 6459157. doi: 10.1093/cid/ciab1025.
PubMed Abstract available

KHAN K, Lustig G, Bernstein M, Archary D, et al
Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIV.
Clin Infect Dis. 2021 Dec 10. pii: 6459255. doi: 10.1093/cid/ciab1008.
PubMed Abstract available

ROCCO JM, Mallarino-Haeger C, Randolph AH, Ray SM, et al
Hyperinflammatory syndromes after SARS-CoV-2 mRNA vaccination in individuals with underlying immune dysregulation.
Clin Infect Dis. 2021 Dec 10. pii: 6459155. doi: 10.1093/cid/ciab1024.
PubMed Abstract available

FERNANDEZ-GONZALEZ M, Agullo V, Padilla S, Garcia JA, et al
Clinical performance of a standardized SARS-CoV-2 interferon-gamma release assay for simple detection of T-cell responses after infection or vaccination.
Clin Infect Dis. 2021 Dec 10. pii: 6459152. doi: 10.1093/cid/ciab1021.
PubMed Abstract available

HUANG YC, Sun HY, Sheng WH, Hsieh SM, et al
Evolution of hepatitis B virus (HBV) serologic markers among antiretroviral-naive, young people living with HIV who had undergone neonatal HBV vaccination and initiated antiretroviral therapy.
Clin Infect Dis. 2021 Dec 10. pii: 6459150. doi: 10.1093/cid/ciab1020.
PubMed Abstract available

BUTT AA, Yan P, Shaikh OS, Mayr FB, et al
Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons with Breakthrough SARS-CoV-2 Infection in a High-risk National Population.
Clin Infect Dis. 2021 Dec 10. pii: 6459161. doi: 10.1093/cid/ciab1023.
PubMed Abstract available

TANG L, Cherry S, Tuomanen EI, Roubidoux EK, et al
Host predictors of broadly cross-reactive antibodies against SARS-CoV-2 variants of concern differ between infection and vaccination.
Clin Infect Dis. 2021 Dec 10. pii: 6458694. doi: 10.1093.
PubMed Abstract available

GANAIE F, Branche AR, Peasley M, Rosch JW, et al
Oral streptococci expressing pneumococci-like cross-reactive capsule types can affect WHO recommended pneumococcal carriage procedure.
Clin Infect Dis. 2021 Dec 10. pii: 6459029. doi: 10.1093/cid/ciab1003.
PubMed Abstract available

LEWIS NM, Chung JR, Uyeki TM, Grohskopf L, et al
Interpretation of Relative Efficacy and Effectiveness for Influenza Vaccines.
Clin Infect Dis. 2021 Dec 7. pii: 6455504. doi: 10.1093/cid/ciab1016.
PubMed Abstract available

HAN A, Czajkowski L, Rosas LA, Cervantes-Medina A, et al
Safety and Efficacy of CR6261 in an Influenza A H1N1 Healthy Human Challenge Model.
Clin Infect Dis. 2021;73:e4260-e4268.
PubMed Abstract available

WANG W, Alvarado-Facundo E, Vassell R, Collins L, et al
Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018-2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant Hemagglutinin.
Clin Infect Dis. 2021;73:e4312-e4320.
PubMed Abstract available

MCCONEGHY KW, Davidson HE, Canaday DH, Han L, et al
Cluster-randomized Trial of Adjuvanted Versus Nonadjuvanted Trivalent Influenza Vaccine in 823 US Nursing Homes.
Clin Infect Dis. 2021;73:e4237-e4243.
PubMed Abstract available

SKOFF TH, Faulkner AE, Liang JL, Barnes M, et al
Pertussis Infections Among Pregnant Women in the United States, 2012-2017.
Clin Infect Dis. 2021;73:e3836-e3841.
PubMed Abstract available

BOZIO CH, Blain A, Edge K, Farley MM, et al
Clinical Characteristics and Adverse Clinical Outcomes of Invasive Haemophilus influenzae Serotype a Cases-United States, 2011-2015.
Clin Infect Dis. 2021;73:e3670-e3676.
PubMed Abstract available

USUF E, Bottomley C, Gladstone R, Bojang E, et al
Persistent and Emerging Pneumococcal Carriage Serotypes in a Rural Gambian Community After 10 Years of Pneumococcal Conjugate Vaccine Pressure.
Clin Infect Dis. 2021;73:e3825-e3835.
PubMed Abstract available

PEPPA M, Thomas SL, Minassian C, Walker JL, et al
Seasonal Influenza Vaccination During Pregnancy and the Risk of Major Congenital Malformations in Live-born Infants: A 2010-2016 Historical Cohort Study.
Clin Infect Dis. 2021;73:e4296-e4304.
PubMed Abstract available

REZAHOSSEINI O, Sorensen SS, Perch M, Ekenberg C, et al
Measles, Mumps, Rubella, and Varicella Zoster Virus Serology and Infections in Solid Organ Transplant Recipients During the First Year Posttransplantation.
Clin Infect Dis. 2021;73:e3733-e3739.
PubMed Abstract available

SPINELLI MA, Peluso MJ, Lynch KL, Yun C, et al
Differences in Post-mRNA Vaccination SARS-CoV-2 IgG Concentrations and Surrogate Virus Neutralization Test Response by HIV Status and Type of Vaccine: a Matched Case-Control Observational Study.
Clin Infect Dis. 2021 Dec 5. pii: 6453392. doi: 10.1093/cid/ciab1009.
PubMed Abstract available

MILLER AD, Zambrano LD, Yousaf AR, Abrams JY, et al
Multisystem Inflammatory Syndrome in Children-United States, February 2020-July 2021.
Clin Infect Dis. 2021 Dec 5. pii: 6453395. doi: 10.1093/cid/ciab1007.
PubMed Abstract available

PANNUS P, Neven KY, De Craeye S, Heyndrickx L, et al
Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naive residents of nursing homes.
Clin Infect Dis. 2021 Dec 3. pii: 6448839. doi: 10.1093.
PubMed Abstract available

November 2021

GRUNAU B, Asamoah-Boaheng M, Lavoie PM, Karim ME, et al
A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval.
Clin Infect Dis. 2021 Nov 30. pii: 6446287. doi: 10.1093.
PubMed Abstract available

BELAY ED, Godfred Cato S, Rao AK, Abrams J, et al
Multisystem Inflammatory Syndrome in Adults after SARS-CoV-2 infection and COVID-19 vaccination.
Clin Infect Dis. 2021 Nov 28. pii: 6445178. doi: 10.1093.
PubMed Abstract available

CHUA GT, Kwan MYW, Chui CSL, Smith RD, et al
Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination.
Clin Infect Dis. 2021 Nov 28. pii: 6445179. doi: 10.1093.
PubMed Abstract available

DIMEGLIO C, Herin F, Da-Silva I, Porcheron M, et al
Post-vaccination SARS-CoV-2 antibody kinetics and protection duration.
Clin Infect Dis. 2021 Nov 27. pii: 6444809. doi: 10.1093.
PubMed

CORREA H, Soslow JH, Dendy JM, Creech CB, et al
Acute myopericarditis post intravenous injection of COVID-19 mRNA vaccine differs from viral myocarditis.
Clin Infect Dis. 2021 Nov 26. pii: 6443709. doi: 10.1093.
PubMed

LI C, Chen Y, Zhao Y, Christopher Lung D, et al
Corrigendum to: Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model.
Clin Infect Dis. 2021 Nov 25. pii: 6438764. doi: 10.1093.
PubMed

GAZIT S, Mizrahi B, Kalkstein N, Neuberger A, et al
BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure: Analysis of Household Members of COVID-19 Patients.
Clin Infect Dis. 2021 Nov 24. pii: 6437962. doi: 10.1093.
PubMed Abstract available

STRATHDEE SA, Abramovitz D, Harvey-Vera A, Vera CF, et al
Correlates of Coronavirus Disease 2019 (COVID-19) Vaccine Hesitancy Among People Who Inject Drugs in the San Diego-Tijuana Border Region.
Clin Infect Dis. 2021 Nov 22. pii: 6433374. doi: 10.1093.
PubMed Abstract available

CANADAY DH, Oyebanji OA, Keresztesy D, Payne M, et al
Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination.
Clin Infect Dis. 2021 Nov 19. pii: 6432026. doi: 10.1093.
PubMed Abstract available

MADELON N, Lauper K, Breville G, Sabater Royo I, et al
Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study.
Clin Infect Dis. 2021 Nov 17. pii: 6430423. doi: 10.1093.
PubMed Abstract available

POLLOCK L, Bennett A, Jere KC, Mandolo J, et al
Plasma rotavirus-specific IgA and risk of rotavirus vaccine failure in infants in Malawi.
Clin Infect Dis. 2021 Nov 12. pii: 6426173. doi: 10.1093.
PubMed Abstract available

LIEN CE, Kuo TY, Lin YJ, Lian WC, et al
Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.
Clin Infect Dis. 2021 Nov 5. pii: 6421519. doi: 10.1093.
PubMed Abstract available

PEREZ Y, Levy ER, Joshi AY, Virk A, et al
Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination.
Clin Infect Dis. 2021 Nov 3. pii: 6420408. doi: 10.1093.
PubMed Abstract available

SHERMAN AC, Desjardins M, Cheng CA, Bausk B, et al
SARS-CoV-2 mRNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity.
Clin Infect Dis. 2021 Nov 2. pii: 6415965. doi: 10.1093.
PubMed Abstract available

BOSCH W, Cowart JB, Bhakta S, Carter RE, et al
COVID-19 Vaccine-Breakthrough Infections Requiring Hospitalization in Mayo Clinic Florida through August 2021.
Clin Infect Dis. 2021 Nov 2. pii: 6415962. doi: 10.1093.
PubMed Abstract available

BRAMUGY J, Mucasse H, Massora S, Vitorino P, et al
Short and long-term outcomes of GBS invasive disease in Mozambican children: Results of a case cohort and retrospective observational study and implications for future vaccine introduction.
Clin Infect Dis. 2021 Nov 2. pii: 6388780. doi: 10.1093.
PubMed Abstract available

MALVOLTI S, Pecenka C, Mantel C, Malhame M, et al
A financial and global demand analysis to inform decisions for funding and clinical development of GBS vaccines for pregnant women.
Clin Infect Dis. 2021 Nov 2. pii: 6412619. doi: 10.1093.
PubMed Abstract available

BROWN NE, Blain AE, Burzlaff K, Harrison LH, et al
Racial Disparities in Invasive Haemophilus influenzae Disease-United States, 2008-2017.
Clin Infect Dis. 2021;73:1617-1624.
PubMed Abstract available

BERENSON AB, Hirth JM, Chang M
Prevalence of Genital Human Papillomavirus by Age and Race/Ethnicity Among Males.
Clin Infect Dis. 2021;73:1625-1633.
PubMed Abstract available

MIELLET WR, van Veldhuizen J, Nicolaie MA, Mariman R, et al
Influenza-like Illness Exacerbates Pneumococcal Carriage in Older Adults.
Clin Infect Dis. 2021;73:e2680-e2689.
PubMed Abstract available

THOMPSON RR, Kong CL, Porco TC, Kim E, et al
Herpes Zoster and Postherpetic Neuralgia: Changing Incidence Rates From 1994 to 2018 in the United States.
Clin Infect Dis. 2021;73:e3210-e3217.
PubMed Abstract available

ISHIKAWA T, Okai M, Mochizuki E, Uchiyama T, et al
Bacillus Calmette-Guerin (BCG) Infections at High Frequency in Both AR-CGD and X-CGD Patients Following BCG Vaccination.
Clin Infect Dis. 2021;73:e2538-e2544.
PubMed Abstract available

TESSIER E, Campbell H, Ribeiro S, Fry NK, et al
Impact of Extending the Timing of Maternal Pertussis Vaccination on Hospitalized Infant Pertussis in England, 2014-2018.
Clin Infect Dis. 2021;73:e2502-e2508.
PubMed Abstract available

LEE JH, Lee YB, Cho EJ, Yu SJ, et al
Entecavir Plus Pegylated Interferon and Sequential Hepatitis B Virus Vaccination Increases Hepatitis B Surface Antigen Seroclearance: A Randomized Controlled Proof-of-Concept Study.
Clin Infect Dis. 2021;73:e3308-e3316.
PubMed Abstract available

October 2021

MARSHALL GS, Ghaswalla PK, Bengtson LGS, Buikema AR, et al
Low Meningococcal Vaccination Rates Among Patients With Newly Diagnosed Complement Component Deficiencies in the United States.
Clin Infect Dis. 2021 Oct 28. pii: 6413775. doi: 10.1093.
PubMed Abstract available

WILLIAMS LR, Ferguson NM, Donnelly CA, Grassly NC, et al
Measuring vaccine efficacy against infection and disease in clinical trials: sources and magnitude of bias in COVID-19 vaccine efficacy estimates.
Clin Infect Dis. 2021 Oct 26. pii: 6410688. doi: 10.1093.
PubMed Abstract available

THEISS-NYLAND K, Shakya M, Colin-Jones R, Voysey M, et al
Corrigendum to: Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial.
Clin Infect Dis. 2021 Oct 26. pii: 6410706. doi: 10.1093.
PubMed

MUHSEN K, Maimon N, Mizrahi A, Bodenneimer O, et al
Effectiveness of BNT162b2 mRNA COVID-19 vaccine against acquisitions of SARS-CoV-2 among health care workers in long-term care facilities: a prospective cohort study.
Clin Infect Dis. 2021 Oct 26. pii: 6410737. doi: 10.1093.
PubMed Abstract available

WOLDEMESKEL BA, Garliss CC, Blankson JN
mRNA Vaccine-Elicited SARS-CoV-2-Specific T cells Persist at 6 Months and Recognize the Delta Variant.
Clin Infect Dis. 2021 Oct 25. pii: 6409907. doi: 10.1093.
PubMed Abstract available

WALDMAN SE, Buehring T, Escobar DJ, Gohil SK, et al
Secondary Cases of Delta-Variant COVID-19 Among Vaccinated Healthcare Workers with Breakthrough Infections is Rare.
Clin Infect Dis. 2021 Oct 25. pii: 6409806. doi: 10.1093.
PubMed Abstract available

BHIMRAJ A, Morgan RL, Shumaker AH, Lavergne V, et al
Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-Edged Swords.
Clin Infect Dis. 2021 Oct 20. pii: 6398590. doi: 10.1093.
PubMed Abstract available

ROBILOTTI EV, Whiting K, Lucca A, Poon C, et al
Clinical and Genomic Characterization of SARS CoV-2 infections in mRNA Vaccinated Health Care Personnel in New York City.
Clin Infect Dis. 2021 Oct 13. pii: 6396142. doi: 10.1093.
PubMed Abstract available

ISTURIZ R, Grant L, Gray S, Alexander-Parrish R, et al
Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-acquired Pneumonia in Hospitalized US Adults.
Clin Infect Dis. 2021;73:1216-1222.
PubMed Abstract available

LADHANI SN, Campbell H, Andrews N, Parikh SR, et al
First Real-world Evidence of Meningococcal Group B Vaccine, 4CMenB, Protection Against Meningococcal Group W Disease: Prospective Enhanced National Surveillance, England.
Clin Infect Dis. 2021;73:e1661-e1668.
PubMed Abstract available

MARSHALL HS, Maiden MCJ
Impact of a Meningococcal Protein-based Serogroup B Vaccine on Serogroup W Invasive Disease in Children.
Clin Infect Dis. 2021;73:e1669-e1672.
PubMed

HUANG W, Chiu NC, Chi H, Huang FY, et al
Inoculation Age of Bacillus Calmette-Guerin Tokyo-172 Strain and Vaccine-related Adverse Reactions in Taiwan Birth Cohort of 2012-2017.
Clin Infect Dis. 2021;73:e1554-e1559.
PubMed Abstract available

MARIN M, Fiebelkorn AP, Bi D, Coleman LA, et al
Adverse Events Among Young Adults Following a Third Dose of Measles-Mumps-Rubella Vaccine.
Clin Infect Dis. 2021;73:e1546-e1553.
PubMed Abstract available

HURLEY D, Griffin C, Young M, Scott DA, et al
Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age.
Clin Infect Dis. 2021;73:e1489-e1497.
PubMed Abstract available

RIVERA L, Biswal S, Saez-Llorens X, Reynales H, et al
Three years efficacy and safety of Takeda's dengue vaccine candidate (TAK-003).
Clin Infect Dis. 2021 Oct 4. pii: 6381105. doi: 10.1093.
PubMed Abstract available

September 2021

LUNDBO LF, Harboe ZB, Sandholdt H, Smith-Hansen L, et al
Comorbidity increases the risk of invasive meningococcal disease in adults.
Clin Infect Dis. 2021 Sep 27. pii: 6375918. doi: 10.1093.
PubMed Abstract available

MAZUR NI, Lowensteyn YN, Willemsen JE, Gill CJ, et al
Global Respiratory Syncytial Virus-Related Infant Community Deaths.
Clin Infect Dis. 2021;73.
PubMed Abstract available

SRIKANTIAH P, Vora P, Klugman KP
Assessing the Full Burden of Respiratory Syncytial Virus in Young Infants in Low- and Middle-Income Countries: The Importance of Community Mortality Studies.
Clin Infect Dis. 2021;73.
PubMed Abstract available

SNYMAN J, Hwa SH, Krause R, Muema D, et al
Similar antibody responses against SARS-CoV-2 in HIV uninfected and infected individuals on antiretroviral therapy during the first South African infection wave.
Clin Infect Dis. 2021 Sep 2. pii: 6362722. doi: 10.1093.
PubMed Abstract available

August 2021

DAWOOD FS, Varner M, Tita A, Newes-Adeyi G, et al
Incidence, Clinical Characteristics, and Risk Factors of SARS-CoV-2 Infection among Pregnant Individuals in the United States.
Clin Infect Dis. 2021 Aug 19. pii: 6354856. doi: 10.1093.
PubMed Abstract available

May 2021

KOELMAN DLH, Brouwer MC, Ter Horst L, Bijlsma MW, et al
Pneumococcal meningitis in adults: a prospective nationwide cohort studY over a 20-year period.
Clin Infect Dis. 2021 May 24. pii: 6283697. doi: 10.1093.
PubMed Abstract available

March 2021

DEGRAZIA D, Miller FG
SARS-CoV-2 Infection Challenge Experiments in Nonhuman Primates: An Ethical Perspective.
Clin Infect Dis. 2021 Mar 31. pii: 6205379. doi: 10.1093.
PubMed Abstract available

November 2020

DAGAN R, Ben-Shimol S, Benisty R, Regev-Yochay G, et al
A Nationwide Outbreak of Invasive Pneumococcal Disease in Israel Caused by Streptococcus Pneumoniae Serotype 2.
Clin Infect Dis. 2020 Nov 17. pii: 5983781. doi: 10.1093/cid/ciaa1720.
PubMed Abstract available

September 2020

LYKE KE, Singer A, Berry AA, Reyes S, et al
Multidose Priming and Delayed Boosting Improve PfSPZ Vaccine Efficacy against Heterologous P. falciparum Controlled Human Malaria Infection.
Clin Infect Dis. 2020 Sep 12. pii: 5904973. doi: 10.1093/cid/ciaa1294.
PubMed Abstract available

July 2020

HUANG H, Xu C, Liu L, Chen L, et al
Increased protection of earlier use of immunoprophylaxis in preventing perinatal transmission of hepatitis B virus.
Clin Infect Dis. 2020 Jul 8. pii: 5868509. doi: 10.1093.
PubMed Abstract available

June 2020

KANSAGRA K, Parmar D, Mendiratta SK, Patel J, et al
A Phase 3, Randomised, Open-Label, Non-inferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin (HRIG).
Clin Infect Dis. 2020 Jun 17. pii: 5858415. doi: 10.1093.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.